<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?DTDIdentifier.IdentifierValue -//ES//DTD journal article DTD version 5.6.0//EN//XML?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName art560.dtd?><?SourceDTD.Version 5.6.0?><?ConverterInfo.XSLTName elsevier2nlmx2.xsl?><?ConverterInfo.Version 1?><?origin publisher?><?FILEmeta_HLY5195 xml ?><?FILEmain xml ?><?FILEmain pdf ?><?FILEgr1 jpg ?><?FILEgr2 jpg ?><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Heliyon</journal-id><journal-id journal-id-type="iso-abbrev">Heliyon</journal-id><journal-title-group><journal-title>Heliyon</journal-title></journal-title-group><issn pub-type="epub">2405-8440</issn><publisher><publisher-name>Elsevier</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7551365</article-id><article-id pub-id-type="pii">S2405-8440(20)32038-7</article-id><article-id pub-id-type="doi">10.1016/j.heliyon.2020.e05195</article-id><article-id pub-id-type="publisher-id">e05195</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Antimicrobial activity, phytochemical characterization and gas chromatography-mass spectrometry analysis of <italic>Aspilia pluriseta</italic> Schweinf. extracts</article-title></title-group><contrib-group><contrib contrib-type="author" id="au1"><name><surname>Njeru</surname><given-names>Sospeter N.</given-names></name><email>hicogn@gmail.com</email><xref rid="aff1" ref-type="aff">a</xref><xref rid="cor1" ref-type="corresp">&#x02217;</xref><xref rid="fn1" ref-type="fn">1</xref></contrib><contrib contrib-type="author" id="au2"><name><surname>Muema</surname><given-names>Jackson M.</given-names></name><xref rid="aff2" ref-type="aff">b</xref></contrib><aff id="aff1"><label>a</label>Department of Biochemistry, School of Health Sciences, Kisii University, PO Box 408-40200, Kisii, Kenya</aff><aff id="aff2"><label>b</label>Department of Biochemistry, Jomo Kenyatta University of Agriculture and Technology (JKUAT), PO Box 62000-00200, Nairobi, Kenya</aff></contrib-group><author-notes><corresp id="cor1"><label>&#x02217;</label>Corresponding author. <email>hicogn@gmail.com</email></corresp><fn id="fn1"><label>1</label><p id="ntpara0010">Current address: Division of Immunology, Research group on T-Cell Homeostasis &#x00026; Interclonal Competitiveness - Paul-Ehrlich-Institute, Federal Institute for Vaccines and Biomedicines, Paul-Ehrlich-Stra&#x000df;e 51&#x02013;59, 63225 Langen (Hessen), Germany.</p></fn></author-notes><pub-date pub-type="pmc-release"><day>08</day><month>10</month><year>2020</year></pub-date><!-- PMC Release delay is 0 months and 0 days and was based on <pub-date
						pub-type="epub">.--><pub-date pub-type="collection"><month>10</month><year>2020</year></pub-date><pub-date pub-type="epub"><day>08</day><month>10</month><year>2020</year></pub-date><volume>6</volume><issue>10</issue><elocation-id>e05195</elocation-id><history><date date-type="received"><day>1</day><month>8</month><year>2020</year></date><date date-type="rev-recd"><day>3</day><month>10</month><year>2020</year></date><date date-type="accepted"><day>5</day><month>10</month><year>2020</year></date></history><permissions><copyright-statement>&#x000a9; 2020 The Author(s)</copyright-statement><copyright-year>2020</copyright-year><license license-type="CC BY" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).</license-p></license></permissions><abstract id="abs0010"><p><italic>Aspilia pluriseta</italic> is associated with various bioactivities, although with limited scientific justification. In this study, we evaluated the antimicrobial activity, and characterized the phytochemicals of root extracts of <italic>A.&#x000a0;pluriseta</italic> aimed at validating its therapeutic potential. We used BACTEC MGIT&#x02122; 960 system to test for antitubercular activity, disc-diffusion together with the microdilution method to evaluate antimicrobial activities and qualitative phytochemical tests together with gas chromatography-mass spectrometry (GC-MS) analysis to determine the phytochemicals that associated with <italic>A.&#x000a0;pluriseta</italic> extracts activity. We show that methanolic crude extract (at 1 g/mL) had high <italic>Mycobacterium tuberculosis</italic> (MTB) inhibitory activity (0 growth unit) and considerable potency against <italic>Escherichia coli</italic> (11.7 mm), <italic>Staphylococcus aureus</italic> (9.0 mm), and <italic>Candida albicans</italic> (7.7 mm). All the extract fractions exerted remarkable antimycobacterial activities with minimum inhibitory activity of between 6.26 &#x02013; 25 &#x003bc;g/mL. The highest antimicrobial activity of petroleum ether and dichloromethane fraction was against <italic>E.&#x000a0;coli</italic> at inhibition zone diameters of 8.3 mm, and 8.0 mm, respectively, while ethyl acetate fraction was against <italic>S.&#x000a0;aureus</italic> with an inhibition zone of 8.7 mm. Methanolic fraction exhibited broad-spectrum activity against 87.5% of the tested microbes (inhibition zones 6.3&#x02013;8.3 mm). Furthermore, we qualitatively detected terpenoids, alkaloids, and phenolics such as flavonoids, and anthraquinones in extract fractions. GC-MS analysis detected an abundance of fatty acid esters, 2-hydroxy-1-(hydroxymethyl) ethyl ester-hexadecanoic acid, and 2,3-dihydroxy propyl ester-octadecanoic acid and four alkanes. Taken together, we show that <italic>A.&#x000a0;pluriseta</italic> extract fractions (especially ethyl acetate and methanolic fractions) have strong selective antitubercular activity, and thus, we scientifically validate the use of <italic>A.&#x000a0;pluriseta</italic> as a potential source for the discovery of novel antitubercular agents.</p></abstract><abstract abstract-type="teaser" id="abs0015"><p>Tuberculosis; <italic>Mycobacterium tuberculosis</italic>; Drug resistance; Phytochemicals; Fatty acid alkyl esters; Alkanes; Medicinal/herbal plants; Traditional/folk medicine; Microbiology; Pharmaceutical science; Biochemistry; Infectious disease; Pharmacology; Alternative medicine; Laboratory medicine</p></abstract><kwd-group id="kwrds0010"><title>Keywords</title><kwd>Tuberculosis</kwd><kwd><italic>Mycobacterium tuberculosis</italic></kwd><kwd>Drug resistance</kwd><kwd>Phytochemicals</kwd><kwd>Fatty acid alkyl esters</kwd><kwd>Alkanes</kwd><kwd>Medicinal/herbal plants</kwd><kwd>Traditional/folk medicine</kwd><kwd>Microbiology</kwd><kwd>Pharmaceutical science</kwd><kwd>Biochemistry</kwd><kwd>Infectious disease</kwd><kwd>Pharmacology</kwd><kwd>Alternative medicine</kwd><kwd>Laboratory medicine</kwd></kwd-group></article-meta></front><body><sec id="sec1"><label>1</label><title>Introduction</title><p id="p0010">Infectious diseases are a primary cause of global human and animal mortality, which is further aggravated by frequent emergence and re-emergence of opportunistic infections [<xref rid="bib1" ref-type="bibr">1</xref>]. However, one of the major global health challenges is attributed to tuberculosis. Tuberculosis (TB) is the leading cause of mortalities from a single infectious agent, which claimed the lives of over 1 million people, besides making an additional over 10 million people ill in 2018 [<xref rid="bib2" ref-type="bibr">2</xref>,<xref rid="bib3" ref-type="bibr">3</xref>]. In humans, TB is an airborne infection primarily caused by MTB [<xref rid="bib3" ref-type="bibr">3</xref>, <xref rid="bib4" ref-type="bibr">4</xref>]. MTB thrives in the hostile environment of the human lungs, despite a sustained immunological onslaught of the host that prevents the growth of nearly all other bacteria [<xref rid="bib3" ref-type="bibr">3</xref>, <xref rid="bib5" ref-type="bibr">5</xref>]. MTB effectively survives host defenses because of a highly impermeable cellular envelope that covers it. The mycobacterial cell envelope is a complex heteropolymer composed of peptidoglycan covalently attached to arabinogalactan terminated by mycolic acids, specific to mycobacteria. Also, MTB can manipulate the host immunological defense mechanisms to foster its survival in a harsh environment [<xref rid="bib5" ref-type="bibr">5</xref>].</p><p id="p0015">Effective management of MTB is hampered by a number of factors such as; (1) The widespread development of drug resistance (for example, multi-drug resistant TB (MDR-TB) which does not respond to isoniazid and rifampicin, and extensively drug-resistant TB (XDR-TB) which is resistant to isoniazid, rifampin, plus fluoroquinolones and one of the injectable second-line drugs such as amikacin, kanamycin, or capreomycin used in MDR-TB treatment regimens) [<xref rid="bib6" ref-type="bibr">6</xref>,<xref rid="bib7" ref-type="bibr">7</xref>], (2) The manifestation of asymptomatic latent TB infection in nearly a fourth of the global population, (3) Expensive and lengthy treatment regime, (4) Drug toxicity and associated adverse effects, and (5) Slow phase discovery of new antitubercular agents among other factors [<xref rid="bib3" ref-type="bibr">3</xref>, <xref rid="bib8" ref-type="bibr">8</xref>, <xref rid="bib9" ref-type="bibr">9</xref>, <xref rid="bib10" ref-type="bibr">10</xref>]. Therefore, it is clear that further discovery and development of novel complementary treatment options are needed for improved TB treatment and control. This will significantly contribute to the World Health Organization (WHO) EndTB strategy [<xref rid="bib3" ref-type="bibr">3</xref>, <xref rid="bib8" ref-type="bibr">8</xref>, <xref rid="bib11" ref-type="bibr">11</xref>].</p><p id="p0020">Besides TB, there are other Gram-positive, Gram-negative, and fungal pathogens that have acquired noxious drug resistance. These pathogens are often responsible for the hospital- and community-acquired infections including and not limited to methicillin-resistant <italic>Staphylococcus aureus</italic> (MRSA), <italic>Klebsiella pneumoniae,</italic> fluoroquinolone-resistant <italic>Pseudomonas aeruginosa</italic>, <italic>Escherichia coli,</italic> among others [<xref rid="bib12" ref-type="bibr">12</xref>]. Such emerging drug-resistant pathogenic strains are usually not sensitive to the first-line of antimicrobial therapy, thus forcing the use of a second- and third-line treatment option. Besides narrowing the available treatment options, the adoption of second- and third-line classes of drugs is often associated with severe adverse effects [<xref rid="bib13" ref-type="bibr">13</xref>]. This further highlights the need for concerted effort in prospecting for novel formulations that are active against emerging, re-emerging, and drug-resistant pathogenic strain.</p><p id="p0025">Although it is widely accepted that drug discovery is an expensive and time-consuming venture, exploration of certain plant species as an alternative source of pharmaceutical molecules, guided by traditional/indigenous knowledge has been very promising [<xref rid="bib14" ref-type="bibr">14</xref>, <xref rid="bib15" ref-type="bibr">15</xref>, <xref rid="bib16" ref-type="bibr">16</xref>, <xref rid="bib17" ref-type="bibr">17</xref>, <xref rid="bib18" ref-type="bibr">18</xref>, <xref rid="bib19" ref-type="bibr">19</xref>]. The pharmacological activities of plant species are attributed to their phytochemicals such as terpenoids, saponins, flavonoids, glycosides, alkaloids, steroids, among others [<xref rid="bib19" ref-type="bibr">19</xref>, <xref rid="bib20" ref-type="bibr">20</xref>]. The traditional/folk knowledge on medicinal plants has been heavily relied on since ancient times in search of new pharmaceutical molecules, antimicrobials, chemotherapeutics, as well as antitubercular agents [<xref rid="bib20" ref-type="bibr">20</xref>, <xref rid="bib21" ref-type="bibr">21</xref>, <xref rid="bib22" ref-type="bibr">22</xref>, <xref rid="bib23" ref-type="bibr">23</xref>, <xref rid="bib24" ref-type="bibr">24</xref>]. Folk medicine has been applied to treat a wide range of diseases and infections, and reports are suggesting that plant-derived compounds exhibit fewer side effects, are less toxic, have low propensity to develop resistance, and are associated with improved efficacy [<xref rid="bib18" ref-type="bibr">18</xref>, <xref rid="bib20" ref-type="bibr">20</xref>]. Herbal medicine is additionally prevalent in under-developed and developing countries where infectious diseases are common, compounded by poverty, poor hygiene and sanitation, and inaccessibility or high cost of good healthcare [<xref rid="bib25" ref-type="bibr">25</xref>, <xref rid="bib26" ref-type="bibr">26</xref>]. In fact, it is estimated that 80% of the under-developed and developing world population rely on plant-derived remedies for alleviating various ailments [<xref rid="bib19" ref-type="bibr">19</xref>, <xref rid="bib27" ref-type="bibr">27</xref>, <xref rid="bib28" ref-type="bibr">28</xref>, <xref rid="bib29" ref-type="bibr">29</xref>, <xref rid="bib30" ref-type="bibr">30</xref>, <xref rid="bib31" ref-type="bibr">31</xref>]. This fact is reinforced by the findings that plants are a rich source of bioactive molecules as efficacious as synthetic pharmaceutics or that can either be chemically modified to enhance their potency or act as templates for new pharmacophores [<xref rid="bib19" ref-type="bibr">19</xref>, <xref rid="bib32" ref-type="bibr">32</xref>, <xref rid="bib33" ref-type="bibr">33</xref>, <xref rid="bib34" ref-type="bibr">34</xref>, <xref rid="bib35" ref-type="bibr">35</xref>]. Furthermore, plant extracts have multitargeting capacity since they contain multiple small biomolecules in low concentration, but showing synergistic and additive effects. In theory, plant extracts function in a 'polypharmacology' paradigm, entailing the use of a single product against multiple targets. This paradigm is touted as a game-changer against drug-resistant microbial strains, besides being associated with low toxicity and low side effects [<xref rid="bib3" ref-type="bibr">3</xref>]. Therefore, the integration of traditional medicine into modern medicine is under serious consideration so as to ease drug resistance challenges and provide an alternative source for affordable, safe, and effective drugs [<xref rid="bib36" ref-type="bibr">36</xref>, <xref rid="bib37" ref-type="bibr">37</xref>]. However, implementation of such herbal derived medicines requires in-depth scrutiny of their efficacy and identification of specific bioactive constituents [<xref rid="bib17" ref-type="bibr">17</xref>, <xref rid="bib30" ref-type="bibr">30</xref>, <xref rid="bib31" ref-type="bibr">31</xref>, <xref rid="bib38" ref-type="bibr">38</xref>, <xref rid="bib39" ref-type="bibr">39</xref>]. This would provide rational scientific validation and justification for utilization and possible integration into conventional medicine, a measure that could strongly contribute to affordable, improved public health [<xref rid="bib19" ref-type="bibr">19</xref>].</p><p id="p0030">In this study, we used <italic>Aspilia pluriseta</italic> Schweinf. (<italic>Asteraceae</italic>) to investigate its potential antimicrobial activity and characterize the phytochemicals responsible for the bioactivity. <italic>A.&#x000a0;pluriseta</italic> is locally known as Muuti (in Mbeere, Embu, and Kikuyu), Wuti (in Kamba), Ol-oiyabase (in Maasai), and Shilambila (in Luhya) communities of Kenya [<xref rid="bib40" ref-type="bibr">40</xref>]. This plant is widely spread in East, Central, and Southern Africa, especially in open woodlands and grasslands [<xref rid="bib41" ref-type="bibr">41</xref>, <xref rid="bib42" ref-type="bibr">42</xref>]. In East Africa (especially Kenya, Rwanda, and Uganda), the plant has been documented to manage and treat cough, stomach infections, burns, bruises, lacerations, wounds, pimples, ears-, eye-, nose infections, kwashiorkor, fever, worms, and diabetes mellitus with little or no scientific validation [<xref rid="bib40" ref-type="bibr">40</xref>, <xref rid="bib42" ref-type="bibr">42</xref>, <xref rid="bib43" ref-type="bibr">43</xref>, <xref rid="bib44" ref-type="bibr">44</xref>, <xref rid="bib45" ref-type="bibr">45</xref>, <xref rid="bib46" ref-type="bibr">46</xref>, <xref rid="bib47" ref-type="bibr">47</xref>]. There are reports on antiviral activity [<xref rid="bib42" ref-type="bibr">42</xref>], molluscicidal activity [<xref rid="bib48" ref-type="bibr">48</xref>], complement modulating activity [<xref rid="bib49" ref-type="bibr">49</xref>], antihelmintic activity [<xref rid="bib50" ref-type="bibr">50</xref>], antimalarial, and hypoglycaemic activities [<xref rid="bib40" ref-type="bibr">40</xref>, <xref rid="bib47" ref-type="bibr">47</xref>, <xref rid="bib51" ref-type="bibr">51</xref>] of <italic>A.&#x000a0;pluriseta</italic>. However, the scientific evidence of its pharmacological activity against medically important bacteria, especially MTB, is at its early stages. As part of our continuous research efforts to discover novel, potent, antitubercular agents from Kenyans ethnobotanicals, in this study we describe the antitubercular activity of <italic>A.&#x000a0;pluriseta</italic> solvent extract fractions. Our findings demonstrate that <italic>A.&#x000a0;pluriseta</italic> extract fractions (especially ethyl acetate and methanolic fractions) have remarkable selective antitubercular activity, which is partly if not exclusively associated with phytochemicals such as terpenoids, phenolics, alkaloids, fatty acid alkyl esters detected in the extract fractions.</p></sec><sec id="sec2"><label>2</label><title>Methods</title><sec id="sec2.1"><label>2.1</label><title>Plant material collection</title><p id="p0035">We used the ethnopharmacological approach to identify the plant used in this study. The information on its herbal use and preparation among the Mbeere community of Embu County, Kenya, was gleaned from community herbal practitioners and further confirmed from documentation by Riley and Brokensha (1988) in <italic>The Mbeere in Kenya (ii), Botanical identity and use</italic> [<xref rid="bib52" ref-type="bibr">52</xref>]. We collected the plant root materials in an open community field. The plant is not among the endangered species, and therefore no prior permission was sought before sample collection. The sampling was carried out within 0&#x000b0;46&#x02032;27.0&#x02033;S 37&#x000b0;40&#x02032;54.9&#x02033;E; -0.774156, 37.681908 of GPS co-ordinates. A botanist authenticated plant sample identity at Egerton University, Kenya, where voucher specimen number NSN2 was given and deposited.</p></sec><sec id="sec2.2"><label>2.2</label><title>Extraction and fractionation of active ingredients</title><p id="p0040">The root samples were mechanically size-reduced, air-dried in the dark at 23 &#x000b1; 2 &#x000b0;C to a constant weight, then ground into a fine powder using an electric miller (Retsch SR 200, Haan, Germany). In order to mimic the traditional preparation method, a portion of the sample powder (50 g) was subjected to cold extraction in distilled water with occasional shaking, after which the extract was lyophilized. A similar portion was macerated twice in 200 mL methanol (Sigma Aldrich, St. Louis, USA) for 48 h, pooled and filtered using Whatmann 1 filter paper. Excess methanol was evaporated from the filtrate using a rotor evaporator (Laborota 4000 efficient, Heidolph, Germany) and the extract stored at -20 &#x000b0;C until use. Fractionation of the <italic>A.&#x000a0;pluriseta</italic> extract was performed using organic solvents of increasing polarity. Fifty grams of root powder was macerated in 200 mL of petro ether with intermittent shaking for 48 h. Subsequently, the material was filtered through Whatman number-1 filter paper. The residue was additionally re-extracted using the same fresh solvent for 48 h, and after that, the two filtrates pooled together. The resulting marc was air-dried and further extracted with dichloromethane solvent followed by ethyl acetate, and methanol solvent, using the same procedure carried out for petroleum ether. Organic crude extract and solvent fractions were concentrated and reconstituted into appropriate stock solution with 100% dimethyl sulfoxide (DMSO) but diluted appropriately so that the final DMSO in the test sample is 1% DMSO. Water crude extract was reconstituted in physiological saline, which served as its negative control.</p></sec><sec id="sec2.3"><label>2.3</label><title>Antimicrobial activity</title><sec id="sec2.3.1"><label>2.3.1</label><title>Test microorganisms</title><p id="p0045">All the test microorganisms were sourced from Kenya Medical Research Institute (KEMRI), Nairobi. These included; one acid-fast <italic>Mycobacterium tuberculosis</italic> strain H37Rv (ATCC 27294), one Gram-positive; <italic>Staphylococcus aureus</italic> (ATTC 25923) strain and Methicillin-resistant <italic>Staphylococcus aureus</italic> strain (clinical isolate), five Gram-negative bacteria; <italic>Escherichia coli</italic> (ATTC 25922), <italic>Pseudomonas aeruginosa</italic> (ATCC 27853), <italic>Klebsiella pneumoniae</italic> (clinical isolate), <italic>Salmonella typhi</italic> (clinical isolate) and <italic>Shigella sonnei</italic> (clinical isolate), and two fungi; <italic>Candida albicans</italic> (ATTC 90028), <italic>Cryptococcus neoformans</italic> (ATTC 66031).</p></sec><sec id="sec2.3.2"><label>2.3.2</label><title>Antimycobacterial activity</title><p id="p0050">MTB was revived in Lowenstein Jensen slants under previously adopted standard conditions [<xref rid="bib53" ref-type="bibr">53</xref>, <xref rid="bib54" ref-type="bibr">54</xref>] and later subjected to BACTEC MGIT 960 system (BD Biosciences, New York, USA) for antitubercular activity assays [<xref rid="bib55" ref-type="bibr">55</xref>, <xref rid="bib56" ref-type="bibr">56</xref>]. BACTEC MGIT 960 system is a fully automated, high volume, a non-radiometric instrument that undertakes continuous monitoring of culture growth. Growth supplement (0.8 mL) containing a combination of oleic acid, dextrose, bovine albumin, and catalase was added to five 7 mL BBL&#x02122; MGIT&#x02122; tubes labeled GC (growth control), STR (streptomycin), INH (isoniazid), RIF (rifampicin), EMB (ethambutol) to provide essential substrates for the rapid growth of MTB. MTB suspension in 0.1 mL Middlebrook 7H9 broth adjusted to 0.5 McFarland standard with 10 mL sterile physiological saline was aseptically transferred into each BBL&#x02122; MGIT&#x02122; tube and incubated at 37 &#x000b0;C. One hundred microliters of BBL&#x02122; MGIT&#x02122; SIRE (streptomycin, isoniazid, rifampicin, ethambutol) prepared aseptically following the manufacturers' instructions were added into corresponding labeled BBL&#x02122; MGIT&#x02122; tube followed by addition of 0.5 mL of 1% MTB suspension. Streptomycin at 1.0 &#x003bc;g/mL, rifampicin at 1.0 &#x003bc;g/mL, ethambutol at 5.0 &#x003bc;g/mL, and isoniazid at 0.1 &#x003bc;g/mL were used as the positive controls whereas 1% DMSO (for solvent extract, and solvent extract fractions), and sterile physiological saline (for water extract) were used as negative controls. The protocol was repeated using crude extracts at 1.0 g/mL (for screening purposes) in place of SIRE and solvent fractions tested at concentrations ranging from 50 to 6.25 &#x003bc;g/mL for petroleum ether, dichloromethane, and methanol, and 25 to 3.125 &#x003bc;g/mL for ethyl acetate to determine the MTB minimum inhibitory concentration (MIC).</p></sec><sec id="sec2.3.3"><label>2.3.3</label><title>Disc diffusion test</title><p id="p0055">To evaluate the general antimicrobial activity of <italic>A.&#x000a0;pluriseta</italic> crude and solvent fractions extracts at various specified concentrations, we used the modified disc diffusion method [<xref rid="bib57" ref-type="bibr">57</xref>, <xref rid="bib58" ref-type="bibr">58</xref>, <xref rid="bib59" ref-type="bibr">59</xref>, <xref rid="bib60" ref-type="bibr">60</xref>, <xref rid="bib61" ref-type="bibr">61</xref>]. A fresh microbial inoculum was made by suspending activated colonies in physiological saline. The bacterial and fungal suspensions were adjusted to 1.5 &#x000d7; 10<sup>6</sup> CFU/mL using 0.5 McFarland turbidity standard and aseptically inoculated onto Muller Hinton agar (MHA) and Sabouraud Dextrose agar (SDA) plates, respectively. Sterilized Whatmann 1 filter paper discs (diameter 6 mm) were impregnated with 10 &#x003bc;L of stock extract solutions (1.0 g/mL crude methanol and water extracts, 500 &#x003bc;g/mL for petroleum ether, dichloromethane, methanolic fractions, and 250 &#x003bc;g/mL for ethyl acetate fraction (inadequate amounts)). Three standard drugs were used as antibiotics positive controls; Oxacillin at 10 &#x003bc;g/disc (Oxoid Ltd, Tokyo, Japan) for Gram-positive bacteria, Gentamycin at 10 &#x003bc;g/disc (Oxoid Ltd, Tokyo, Japan) for Gram-negative bacteria, and Nystatin at 100 &#x003bc;g/disc (Oxoid Ltd, Tokyo, Japan) for all fungi. Whatmann filter paper discs loaded with 10 &#x003bc;L of 1% DMSO (for solvent extract, and solvent extract fractions), and 10 &#x003bc;L of sterile physiological saline (for water crude extract) served as negative controls. Air-dried discs were carefully placed on the agar plates at equidistance points using sterile forceps, including both positive antibiotic control and negative control discs into each plate. Subsequently, the plates were initially incubated at 4 &#x000b0;C for 2 h to allow pre-diffusion of extracts into media and incubated at 37 &#x000b0;C for 24 h. Antimicrobial activity was assessed in triplicates by measuring the size of the inhibition zone to the nearest mm. Fractions exhibiting strong antimicrobial inhibitory potential were considered for further MIC and minimum microbicidal concentration analysis (MMC) determination [<xref rid="bib62" ref-type="bibr">62</xref>].</p></sec><sec id="sec2.3.4"><label>2.3.4</label><title>Determination of MIC and MMC</title><p id="p0060">The MIC and MMC of <italic>A.&#x000a0;pluriseta</italic> solvent fractions were analyzed as previously described [<xref rid="bib36" ref-type="bibr">36</xref>, <xref rid="bib57" ref-type="bibr">57</xref>, <xref rid="bib60" ref-type="bibr">60</xref>, <xref rid="bib61" ref-type="bibr">61</xref>, <xref rid="bib63" ref-type="bibr">63</xref>]. Briefly, 50 &#x003bc;L of varying fraction concentrations (3.9&#x02013;500 &#x003bc;g/mL petroleum ether, dichloromethane, and methanol; 1.95&#x02013;250 &#x003bc;g/mL ethyl acetate) were added into 100 &#x003bc;L of nutrient broth held in a sterile 96-well plate followed by addition of 50 &#x003bc;L test organisms adjusted to 0.5 McFarland standard. All concentrations were tested in triplicates at 37 &#x000b0;C for 24 h. A negative control containing 1% DMSO in nutrient broth was included in column 11, while column 12 checked the capacity of the media to support the growth of the test organism. In order to evaluate the microbial growth in each well, 40 &#x003bc;L of 0.2 mg/mL <italic>p</italic>-iodonitrotetrazolium chloride (INT, Sigma) were added and incubated for 30 min. Formation of a pink-red color depicted growth while persistent clear coloration denoted growth inhibition. The lowest solvent fraction concentration that exhibited color change was considered as the MIC. MMC was determined by aseptically streaking a loopful of broth from wells that exhibited no color change onto sterile nutrient agar and SDA for bacteria and fungi, respectively, and thereafter incubated at 37 &#x000b0;C for 24 h. The lowest concentration that exhibited no growth was considered as the MMC [<xref rid="bib64" ref-type="bibr">64</xref>].</p></sec></sec><sec id="sec2.4"><label>2.4</label><title>Phytochemical analysis using GC-MS</title><p id="p0065">We performed a preliminary screening for the presence of various phytochemicals such as alkaloids, terpenoids, phenolics such as flavonoids, and anthraquinones qualitatively as previously reported by us and others [<xref rid="bib4" ref-type="bibr">4</xref>, <xref rid="bib20" ref-type="bibr">20</xref>, <xref rid="bib36" ref-type="bibr">36</xref>, <xref rid="bib65" ref-type="bibr">65</xref>]. Additionally, we undertook a GC-MS analysis of the methanolic extract fraction since it exhibited a broad-spectrum activity. An aliquot of the methanolic fraction (1.3 mg) was dissolved in 1 mL dichloromethane and analyzed with an Agilent Technologies 7890A gas chromatography coupled with a 5975C mass spectrometer in full scan mode (EI, 70 eV, Agilent, Palo Alto, CA). The system was equipped with an HP-5 MS low bleed capillary column (30 m &#x000d7; 0.25 mm i.d., 0.25 &#x003bc;m film thickness (J&#x00026;W, Folsom, CA, USA)). An injection volume of 1 &#x003bc;L was subjected to a splitless mode during analysis, with helium used as the carrier medium at a constant flow rate of 1.25 mL/min. The oven temperature was maintained at 35 &#x000b0;C for 5 min, then programmed to increase at 10 &#x000b0;C/min to 280 &#x000b0;C and held at this temperature for 10.5 min. The obtained compound profiles were identified by comparing the corresponding reference retention indices and mass spectral in databases (NIST 05, NIST 08, Adams, and chemical).</p></sec><sec id="sec2.5"><label>2.5</label><title>Data analyses</title><p id="p0070">The data was analyzed using Analysis of variance (ANOVA) using R (version 3.5.1) with Tukey HSD post-hoc. A <italic>p-</italic>value of less than 0.05 was considered statistically significance. Values were expressed as mean &#x000b1; SEM of experimental replicates.</p></sec></sec><sec id="sec3"><label>3</label><title>Results</title><sec id="sec3.1"><label>3.1</label><title>Screening for general antimicrobial activities of <italic>A.&#x000a0;pluriseta</italic> crude extracts</title><p id="p0075">In order to mimic the traditional preparation of <italic>A.&#x000a0;pluriseta</italic> herbal medicine, we initially assayed for the general bioactivity of the crude water and methanol extracts. Using a BACTEC MGIT&#x02122; 960 system (BD, New York, USA) to assay for antimycobacterial activity, we found that the water crude extract had no antituberculous activity (400 growth unit (GU)), equivalent to GU of the negative control. Interestingly, the methanolic crude extract exhibited high inhibitory activity against MTB similar to SIRE positive control (0 GU; <xref rid="tbl1" ref-type="table">Table&#x000a0;1</xref>).<table-wrap position="float" id="tbl1"><label>Table&#x000a0;1</label><caption><p>Screening for the antimycobacterial activity of <italic>A.&#x000a0;pluriseta</italic> crude extracts.</p></caption><alt-text id="alttext0020">Table&#x000a0;1</alt-text><table frame="hsides" rules="groups"><thead><tr><th>Sample</th><th>Solvent</th><th>GU</th><th>NR/S</th></tr></thead><tbody><tr><td rowspan="4"><italic>A.&#x000a0;pluriseta</italic></td><td>Water</td><td>400</td><td>NR</td></tr><tr><td>Methanol</td><td>0</td><td>S</td></tr><tr><td>SIRE</td><td>0</td><td>S</td></tr><tr><td>GC</td><td>400</td><td>NR</td></tr></tbody></table><table-wrap-foot><fn><p>Water and methanol crude extract at 1 g/mL; SIRE: Positive control of streptomycin at 1.0 &#x003bc;g/mL, isoniazid at 0.5 &#x003bc;g/mL, rifampicin at 1.0 &#x003bc;g/mL and ethambutol at 5.0 &#x003bc;g/mL; GC: Growth control acting as a negative control of media treated with 1% DMSO (methanolic crude extract) or physiological saline (water crude extract); NR: Non-responsive; S: Sensitive.</p></fn></table-wrap-foot></table-wrap></p><p id="p0080">Further, we screened for general antimicrobial activity by disc diffusion method against representative Gram-positive bacteria (<italic>S.&#x000a0;aureus</italic>), Gram-negative bacteria (<italic>E.&#x000a0;coli</italic>), and fungi (<italic>C.&#x000a0;albicans</italic>). Our results demonstrated a significant difference in antimicrobial activities of tested extracts against test microbes relative to controls (ANOVA, <italic>S.&#x000a0;aureus</italic>; F<sub>(3,8)</sub> = 160.1, <italic>p</italic> &#x0003c; 0.001; <italic>E.&#x000a0;coli</italic>, F<sub>(3,8)</sub> = 53.67, <italic>p</italic> &#x0003c; 0.001; <italic>C.&#x000a0;albicans</italic>, F<sub>(3,8)</sub> = 72.67, <italic>p</italic> &#x0003c; 0.001). The water extract exhibited low general antimicrobial activity in all tested cases (zone of inhibition &#x0003c;10 mm), while the methanolic crude extract gave moderate but broad-spectrum activity, with the highest inhibition of 11.7 mm against <italic>E.&#x000a0;coli</italic> (<xref rid="tbl2" ref-type="table">Table&#x000a0;2</xref>).<table-wrap position="float" id="tbl2"><label>Table&#x000a0;2</label><caption><p>Screening for general antimicrobial activity of <italic>A.&#x000a0;pluriseta</italic> crude extracts.</p></caption><alt-text id="alttext0025">Table&#x000a0;2</alt-text><table frame="hsides" rules="groups"><thead><tr><th rowspan="2">Sample</th><th rowspan="2">Extract</th><th colspan="3">The diameter of zone of inhibition (mm)<hr/></th></tr><tr><th><italic>S.&#x000a0;aureus</italic></th><th><italic>E.&#x000a0;coli</italic></th><th><italic>C.&#x000a0;albicans</italic></th></tr></thead><tbody><tr><td rowspan="4"><italic>A.&#x000a0;pluriseta</italic></td><td>Water</td><td>6.7 &#x000b1; 0.3<sup>ab</sup></td><td>7 &#x000b1; 0.6 <sup>ab</sup></td><td>6.0 &#x000b1; 0<sup>ab</sup></td></tr><tr><td>Methanol</td><td>9.0 &#x000b1; 0.6 <sup>ab</sup></td><td>11.7 &#x000b1; 0.3<sup>b</sup></td><td>7.7 &#x000b1; 0.3 <sup>ab</sup></td></tr><tr><td>Positive control</td><td>24.0 &#x000b1; 1.3</td><td>22.0 &#x000b1; 0</td><td>16.3 &#x000b1; 0.9</td></tr><tr><td>Negative control</td><td>0</td><td>0</td><td>0</td></tr></tbody></table><table-wrap-foot><fn><p>Water and methanol crude extract at 10 &#x000d7; 10<sup>4</sup> &#x003bc;g; Positive control (Oxacillin 10 &#x003bc;g/disc for Gram-positive, Gentamycin 10 &#x003bc;g/disc for Gram-negative bacteria and Nystatin 100 &#x003bc;g/disc for fungi); Negative control (Discs loaded with 10 &#x003bc;L of 1% DMSO (for methanol extract) or physiological saline (for water extract)); n = 3; Values = Mean &#x000b1; SEM. Values followed by similar superscript letters are not significantly different from each other (ANOVA - Tukey's post-hoc multiple comparisons, <italic>P</italic> &#x0003c; 0.05).</p></fn></table-wrap-foot></table-wrap></p><p id="p0085">Even though the crude extract concentrations were in the range of 10<sup>4</sup> times higher than the standard antibiotic controls, methanolic crude extract showed a remarkable antitubercular activity, that compared with the activity of the positive control. Since the active components in the crude extract could have comprised only a fraction of the total extract used, we reasoned that further purification would allow enrichment of active molecules in extract fractions. Therefore, we hypothesized that extract solvent fractionation would result in enhanced activity, and possibly at a lower concentration.</p></sec><sec id="sec3.2"><label>3.2</label><title>Antimycobacterial activities of <italic>A.&#x000a0;pluriseta</italic> solvent extract fractions</title><p id="p0090">To test whether fractionation of <italic>A.&#x000a0;pluriseta</italic> could lead to improved antimycobacterial activity, as well as determine the MIC of different fractions, we used the BACTEC MGIT 960 system. If the GU of the extract fraction-containing tubes was greater than 100 when the GU of the growth control was 400, we defined the results as non-responsive. However, if the GU values of the extract fraction-containing tubes were &#x02264;100, the results were considered susceptible, and the concentration of that tube was used to define the MIC [<xref rid="bib55" ref-type="bibr">55</xref>, <xref rid="bib56" ref-type="bibr">56</xref>]. Our results revealed the most robust activity against MTB by more polar ethyl acetate (EA) fraction (MIC 6.25 &#x003bc;g/mL) followed by methanolic (MeOH) fraction (12.5 &#x003bc;g/mL). The less polar dichloromethane (DCM) and petroleum ether (PE) fractions had a MIC of 25 &#x003bc;g/mL, with DCM fraction inhibiting MTB growth in a dose-dependent manner (<xref rid="tbl3" ref-type="table">Table&#x000a0;3</xref>). For EA and MeOH fractions, concentrations &#x02265;6.25 and 12.5 &#x003bc;g/mL, respectively, completely inhibited MTB growth, an observation comparable to a positive control (SIRE). These results confirmed our hypothesis that <italic>A.&#x000a0;pluriseta</italic> fractionation would lead to robust antitubercular activity, and at a lower concentration. Further, the results are in agreement with other studies that have reported polar solvent extract fractions usually have higher activity than less polar fractions [<xref rid="bib66" ref-type="bibr">66</xref>, <xref rid="bib67" ref-type="bibr">67</xref>, <xref rid="bib68" ref-type="bibr">68</xref>].<table-wrap position="float" id="tbl3"><label>Table&#x000a0;3</label><caption><p>Antimycobacterial activity of <italic>A.&#x000a0;pluriseta</italic> solvent extract fractions.</p></caption><alt-text id="alttext0030">Table&#x000a0;3</alt-text><table frame="hsides" rules="groups"><thead><tr><th>Plant</th><th>Fraction</th><th>Concentration &#x003bc;g/mL</th><th>GU</th><th>NR/S</th><th>MIC (&#x003bc;g/mL)</th></tr></thead><tbody><tr><td rowspan="20"><italic>A.&#x000a0;pluriseta</italic></td><td>PE</td><td>50</td><td>0</td><td>S</td><td rowspan="5">25</td></tr><tr><td/><td>25</td><td>0</td><td>S</td></tr><tr><td/><td>12.5</td><td>400</td><td>NR</td></tr><tr><td/><td>GC</td><td>400</td><td>NR</td></tr><tr><td/><td>SIRE</td><td>0</td><td>S</td></tr><tr><td>DCM</td><td>50</td><td>0</td><td>S</td><td rowspan="5">25</td></tr><tr><td/><td>25</td><td>3</td><td>S</td></tr><tr><td/><td>12.5</td><td>132</td><td>S</td></tr><tr><td/><td>GC</td><td>400</td><td>NR</td></tr><tr><td/><td>SIRE</td><td>0</td><td>S</td></tr><tr><td>EA</td><td>25</td><td>0</td><td>S</td><td rowspan="5">6.25</td></tr><tr><td/><td>12.5</td><td>0</td><td>S</td></tr><tr><td/><td>6.25</td><td>0</td><td>S</td></tr><tr><td/><td>GC</td><td>400</td><td>NR</td></tr><tr><td/><td>SIRE</td><td>0</td><td>S</td></tr><tr><td>MeOH</td><td>50</td><td>0</td><td>S</td><td rowspan="5">12.5</td></tr><tr><td/><td>25</td><td>0</td><td>S</td></tr><tr><td/><td>12.5</td><td>0</td><td>S</td></tr><tr><td/><td>GC</td><td>400</td><td>NR</td></tr><tr><td/><td>SIRE</td><td>0</td><td>S</td></tr></tbody></table><table-wrap-foot><fn><p>PE: Petroleum ether fraction; DCM: Dichloromethane fraction; EA: Ethyl acetate fraction; MeOH: Methanol fraction; SIRE: Positive control of streptomycin at 1.0 &#x003bc;g/mL, isoniazid at 0.5 &#x003bc;g/mL, rifampicin at 1.0 &#x003bc;g/mL and ethambutol at 5.0 &#x003bc;g/ml; GU: Growth unit; GC: Growth control as the negative control of media treated with 1% DMSO; <bold>N</bold>R: Non-responsive; S: Sensitive.</p></fn></table-wrap-foot></table-wrap></p></sec><sec id="sec3.3"><label>3.3</label><title>General antimicrobial activities, MIC and MMC of <italic>A.&#x000a0;pluriseta</italic> extract fractions</title><p id="p0095">With crude solvent extract having demonstrated moderate broad-spectrum antimicrobial activity, we reasoned that solvent fractionation might yield improved antimicrobial activity. However, fractionation of root extract with solvents of increasing polarities resulted in attenuated but broad-spectrum mild antimicrobial activity, with all fractions giving inhibitory zones of less than 10 mm (<xref rid="tbl4" ref-type="table">Table&#x000a0;4</xref>). The best activity (though still a weak one) by petroleum ether fraction was against <italic>E.&#x000a0;coli</italic> (zone of inhibition 8.3 mm), dichloromethane against <italic>E.&#x000a0;coli</italic> (8.0 mm), ethyl acetate against <italic>S.&#x000a0;aureus</italic> (8.7 mm) and methanolic against <italic>S.&#x000a0;aureus</italic> (8.3 mm), <italic>C.&#x000a0;albicans</italic> (8.3 mm) and against <italic>E.&#x000a0;coli</italic> (8.0 mm) (<xref rid="tbl4" ref-type="table">Table&#x000a0;4</xref>). EA fraction showed a weak growth inhibition against <italic>C.&#x000a0;neoformans</italic> (zone of inhibition 6.7 mm), while MeOH fraction weakly inhibited <italic>K.&#x000a0;pneumonia</italic> (zone of inhibition 7.0 mm). Generally, the methanolic extract fraction exhibited significant broad spectrum activity against seven of the eight tested microorganisms (ANOVA; <italic>S.&#x000a0;aureus</italic>, F<sub>(5,12)</sub> = 2267, <italic>p</italic> &#x0003c; 0.001; MRSA, F<sub>(4,10)</sub> = 129.7, <italic>p</italic> &#x0003c; 0.001; PA, F<sub>(5,12)</sub> = 2464, <italic>p</italic> &#x0003c; 0.001; <italic>E.&#x000a0;coli</italic>, F<sub>(5,12)</sub> = 248.3, <italic>p</italic> &#x0003c; 0.001; KP, F<sub>(5,12)</sub> = 922.1, <italic>p</italic> &#x0003c; 0.001; S.S, F<sub>(5,12)</sub> = 507, <italic>p</italic> &#x0003c; 0.001; ST, F<sub>(5,12)</sub> = 143.7; <italic>p</italic> &#x0003c; 0.001; CN, F<sub>(3,8)</sub> = 1849; <italic>p</italic> &#x0003c; 0.001; CA, F<sub>(5,12)</sub> = 302.7; <italic>p</italic> &#x0003c; 0.001). Equally, relative to the negative controls, all the extract fractions significantly inhibited the growth of tested microorganisms (<italic>p</italic> &#x0003c; 0.001) but in a manner less comparable to the positive control.<table-wrap position="float" id="tbl4"><label>Table&#x000a0;4</label><caption><p>Antimicrobial activity of <italic>A.&#x000a0;pluriseta</italic> solvent extract fractions.</p></caption><alt-text id="alttext0035">Table&#x000a0;4</alt-text><table frame="hsides" rules="groups"><thead><tr><th rowspan="3">Fractions</th><th colspan="9">The diameter of zone of inhibition (mm)<hr/></th></tr><tr><th colspan="2">Gram-positive<hr/></th><th colspan="5">Gram-negative<hr/></th><th colspan="2">Fungi<hr/></th></tr><tr><th>SA</th><th>MRSA</th><th>PA</th><th>EC</th><th>KP</th><th>SS</th><th>ST</th><th>CA</th><th>CN</th></tr></thead><tbody><tr><td>PE</td><td>7.7 &#x000b1; 0.3<sup>ab</sup></td><td>NT</td><td>0<sup>b</sup></td><td>8.3 &#x000b1; 0.3<sup>ab</sup></td><td>0<sup>b</sup></td><td>0<sup>b</sup></td><td>0<sup>b</sup></td><td>7.7 &#x000b1; 0.3<sup>ab</sup></td><td>NT</td></tr><tr><td>DCM</td><td>7.7 &#x000b1; 0.3<sup>ab</sup></td><td>0<sup>b</sup></td><td>0<sup>b</sup></td><td>8.0&#x000b1;0<sup>ab</sup></td><td>0<sup>b</sup></td><td>7.7 &#x000b1; 0.3<sup>ab</sup></td><td>0<sup>b</sup></td><td>7.3 &#x000b1; 0.3<sup>ab</sup></td><td>0<sup>b</sup></td></tr><tr><td>EA</td><td>8.7 &#x000b1; 0.3<sup>ab</sup></td><td>0<sup>b</sup></td><td>0<sup>b</sup></td><td>0<sup>b</sup></td><td>0<sup>b</sup></td><td>0<sup>b</sup></td><td>0<sup>b</sup></td><td>0<sup>b</sup></td><td>6.7 &#x000b1; 0.3<sup>ab</sup></td></tr><tr><td>MeOH</td><td>8.3 &#x000b1; 0.3<sup>ab</sup></td><td>6.3 &#x000b1; 0.3<sup>ab</sup></td><td>0<sup>b</sup></td><td>8.0&#x000b1;0<sup>ab</sup></td><td>7.0&#x000b1;0<sup>ab</sup></td><td>8.0&#x000b1;0<sup>ab</sup></td><td>6.7 &#x000b1; 0.3<sup>ab</sup></td><td>8.3 &#x000b1; 0.3<sup>ab</sup></td><td>NT</td></tr><tr><td>PC</td><td>33.7 &#x000b1; 0.3</td><td>24.3 &#x000b1; 0.3</td><td>23.7 &#x000b1; 0.6</td><td>15 &#x000b1; 0</td><td>15.7 &#x000b1; 0.3</td><td>19.7 &#x000b1; 0.6</td><td>21.3 &#x000b1; 0.3</td><td>16.3 &#x000b1; 0.3</td><td>20.3 &#x000b1; 0.3</td></tr><tr><td>NC</td><td>0</td><td>0</td><td>0</td><td>0</td><td>0</td><td>0</td><td>0</td><td>0</td><td>0</td></tr></tbody></table><table-wrap-foot><fn><p>PE: Petroleum ether fraction at 5 &#x003bc;g/disc; DCM: Dichloromethane fraction at 5 &#x003bc;g/disc; EA: Ethyl acetate fraction at 2.5 &#x003bc;g/disc; MeOH: Methanol fraction at 5 &#x003bc;g/disc; PA: <italic>Pseudomonas aeruginosa</italic>; EC: <italic>Escherichia coli</italic>; SA: <italic>Staphylococcus aureus</italic>; KP: <italic>Klebsiella pneumoniae</italic>; MRSA: <italic>Methicillin Resistant Staphylococcus aureus</italic>; SS: <italic>Shigella sonnei</italic>; ST: <italic>Salmonella typhi</italic>; CA: <italic>Candida albicans</italic>; CN: <italic>Cryptococcus neoformans</italic>; PC: Positive control (Oxacillin 10 &#x003bc;g/disc and Gentamycin 10 &#x003bc;g/disc for Gram positive and Gram negative bacteria respectively. Nystatin 100 &#x003bc;g/disc for fungi); NC: Negative control (Discs loaded with 10 &#x003bc;l of 1% DMSO); <italic>n</italic> = 3; values = Mean &#x000b1; SEM; Values followed by similar superscript letters are not significantly different from each other (ANOVA - Tukey's post-hoc multiple comparisons, P &#x0003c; 0.05).</p></fn></table-wrap-foot></table-wrap></p><p id="p0100">Further, we tested for the MIC and MMC concentrations of the solvent extract fractions (<xref rid="tbl5" ref-type="table">Table&#x000a0;5</xref>), and we established that petroleum ether fraction against <italic>E.&#x000a0;coli</italic> had a MIC of 250 &#x003bc;g/mL while methanolic fraction against <italic>S.&#x000a0;aureus</italic> had a MIC of 125 &#x003bc;g/mL. In all other cases, the MIC was greater than 500 &#x003bc;g/mL indicating that the extract fractions were bacteriostatic in action.<table-wrap position="float" id="tbl5"><label>Table&#x000a0;5</label><caption><p>MIC and MBC of <italic>A.&#x000a0;pluriseta</italic> solvent extract fractions.</p></caption><alt-text id="alttext0040">Table&#x000a0;5</alt-text><table frame="hsides" rules="groups"><thead><tr><th rowspan="3">Fractions</th><th colspan="9">MIC (&#x003bc;g/ml)<hr/></th></tr><tr><th colspan="2">Gram-positive<hr/></th><th colspan="5">Gram-negative<hr/></th><th colspan="2">Fungi<hr/></th></tr><tr><th>SA</th><th>MRSA</th><th>PA</th><th>EC</th><th>KP</th><th>SS</th><th>ST</th><th>CA</th><th>CN</th></tr></thead><tbody><tr><td>PE</td><td>-</td><td>-</td><td>-</td><td>250</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td></tr><tr><td>DCM</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td></tr><tr><td>EA</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td></tr><tr><td>MOH</td><td>125</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td></tr></tbody></table><table-wrap-foot><fn><p>PE: Petroleum ether fraction; DCM: Dichloromethane fraction; EA: Ethyl acetate fraction; MOH: Methanol fraction; PA: <italic>Pseudomonas aeruginosa</italic>; EC: <italic>Escherichia coli</italic>; SA: <italic>Staphylococcus aureus</italic>; KP: <italic>Klebsiella pneumoniae</italic>; MRSA: <italic>Methicillin-resistant Staphylococcus aureus</italic>; SS: <italic>Shigella sonnei</italic>; ST: <italic>Salmonella typhi</italic>; CA: <italic>Candida albicans</italic>; CN: <italic>Cryptococcus neoformans</italic>; - indicates the MIC is &#x0003e;500 &#x003bc;g/mL; MMC in all cases were &#x0003e;500 &#x003bc;g/mL.</p></fn></table-wrap-foot></table-wrap></p><p id="p0105">Therefore, the general antimicrobial activity results were counterintuitive, considering the fractions yielded robust antimycobacterial activity. This would suggest that the active principles in the extract fractions are, to some extent, specific to acid-fast bacteria. This would be very important for the discovery of selective antitubercular leads, as previously reported [<xref rid="bib69" ref-type="bibr">69</xref>, <xref rid="bib70" ref-type="bibr">70</xref>].</p></sec><sec id="sec3.4"><label>3.4</label><title>Phytochemical analysis</title><p id="p0110">The preliminary examination of <italic>A.&#x000a0;pluriseta</italic> solvent extract fractions pointed to the presence of different phytoconstituents such as terpenoids, alkaloids, and phenolics such as flavonoids, and anthraquinones (<xref rid="tbl6" ref-type="table">Table&#x000a0;6</xref>). We speculate that these are the bioactive constituents that may be responsible for the bioactivity demonstrated by these extract fractions.<table-wrap position="float" id="tbl6"><label>Table&#x000a0;6</label><caption><p>Phytochemical results of <italic>A.&#x000a0;pluriseta</italic> solvent fraction extracts.</p></caption><alt-text id="alttext0045">Table&#x000a0;6</alt-text><table frame="hsides" rules="groups"><thead><tr><th>Extract Fraction</th><th>V-Ts</th><th>A-F</th><th>MK-A</th><th>D-A</th><th>F-P</th></tr></thead><tbody><tr><td>Petrol ether</td><td>+++</td><td>-</td><td>-</td><td>+</td><td>-</td></tr><tr><td>Dichloromethane</td><td>+++</td><td>+</td><td>+</td><td>++</td><td>++</td></tr><tr><td>Ethyl acetate</td><td>+</td><td>+</td><td>+</td><td>-</td><td>+</td></tr><tr><td>Methanol</td><td>+++</td><td>-</td><td>-</td><td>-</td><td>+</td></tr></tbody></table><table-wrap-foot><fn><p><bold>V-T,</bold> Vanillin test for terpenoids; <bold>A-F,</bold> Ammonia test for Flavonoids; <bold>MK-A,</bold> Methanolic Potassium hydroxide test for Anthraquinones; <bold>D-A,</bold> Dragendorff test for Alkaloids; <bold>F-P,</bold> Ferric Chloride test for Phenols; <bold>-,</bold> Absent phytochemicals<bold>; +,</bold> Low concentration of phytochemicals; <bold>++,</bold> Medium concentration; <bold>+++,</bold> High concentration of phytochemicals.</p></fn></table-wrap-foot></table-wrap></p><p id="p0115">Methanolic extract fraction exhibited broad spectrum activity (inhibiting the growth of Gram-negative, Gram-positive, acid-fast bacteria, and fungi (Tables&#x000a0;<xref rid="tbl3" ref-type="table">3</xref> and <xref rid="tbl4" ref-type="table">4</xref>)). Additionally, it was easier to get more materials from this extract fraction for further analysis. Therefore, we subjected this fraction to GC-MS analysis to identify the specific bioactive compounds that could be partly associated with the activity of this fraction (<xref rid="tbl7" ref-type="table">Table&#x000a0;7</xref>; Figures&#x000a0;<xref rid="fig1" ref-type="fig">1</xref> and <xref rid="fig2" ref-type="fig">2</xref>). We detected six compounds from the extract fraction, four alkanes, and two fatty acid esters. Based on the mass spectral library databases, these compounds were tentatively identified as hexadecane, octadecane, eicosane, 2-hydroxy-1-(hydroxymethyl) ethyl ester-hexadecanoic acid, tetracosane, and 2,3-dihydroxy propyl ester-octadecanoic acid (<xref rid="tbl7" ref-type="table">Table&#x000a0;7</xref>; <xref rid="fig2" ref-type="fig">Figure&#x000a0;2</xref>). The fatty acid esters represented by peaks at retention times 28.61 min (2-hydroxy-1-(hydroxymethyl) ethyl ester-hexadecanoic acid) and 30.23 min (2,3-dihydroxy propyl ester-octadecanoic acid) were the most abundant compounds detected (<xref rid="fig1" ref-type="fig">Figure&#x000a0;1</xref>), and it is highly possible that on their own or in combination with other secondary metabolites contributed wholly or in part to the bioactivity of this extract fraction.<table-wrap position="float" id="tbl7"><label>Table&#x000a0;7</label><caption><p>Compounds identified in <italic>A.&#x000a0;pluriseta</italic> methanolic extract fraction using GC-MS.</p></caption><alt-text id="alttext0050">Table&#x000a0;7</alt-text><table frame="hsides" rules="groups"><thead><tr><th>Peak no.</th><th>Rt (min)</th><th>Compound name</th><th>Class</th></tr></thead><tbody><tr><td>1</td><td>26. 84</td><td>Hexadecane</td><td>Alkane</td></tr><tr><td>2</td><td>27.67</td><td>Octadecane</td><td>Alkane</td></tr><tr><td>3</td><td>27.68</td><td>Eicosane</td><td>Alkane</td></tr><tr><td>4</td><td>28.61</td><td>2-hydroxy-1-(hydroxymethyl)ethyl ester-hexadecanoic acid</td><td>Fatty acid ester</td></tr><tr><td>5</td><td>29.24</td><td>Tetracosane</td><td>Alkane</td></tr><tr><td>6</td><td>30.23</td><td>2,3-dihydroxypropyl ester-octadecanoic acid</td><td>Fatty acid ester</td></tr></tbody></table><table-wrap-foot><fn><p>Rt: Retention time in minutes; The data presented in the table above shows the peak number, corresponding retention time, compound identities, and their classification.</p></fn></table-wrap-foot></table-wrap><fig id="fig1"><label>Figure&#x000a0;1</label><caption><p>GC-MS analysis spectrum of <italic>A.&#x000a0;pluriseta</italic> methanolic extract fraction. The spectrum highlights the compound abundance and separation based on mass fragmentation and retention times.</p></caption><alt-text id="alttext0010">Figure&#x000a0;1</alt-text><graphic xlink:href="gr1"/></fig><fig id="fig2"><label>Figure&#x000a0;2</label><caption><p>Compounds identified in <italic>A.&#x000a0;pluriseta</italic> methanolic extract fraction using GC-MS. The chemical structures of the identified compounds (1) Hexadecane, (2) Octadecane, (3) Eicosane, (4) 2-hydroxy-1-(hydroxymethyl)ethyl ester-hexadecanoic acid, (5) Tetracosane, and (6) 2,3-dihydroxy propyl ester-octadecanoic acid.</p></caption><alt-text id="alttext0015">Figure&#x000a0;2</alt-text><graphic xlink:href="gr2"/></fig></p></sec></sec><sec id="sec4"><label>4</label><title>Discussion</title><p id="p0120">Increasing demand for effective antimicrobials to lessen antimicrobial drug resistance burden and accelerate prompt prevention and treatment of microbial infections necessitates the discovery of new pharmaceutical molecules. This calls for a collaborative approach involving the herbal practitioners and scientific community in search of pharmaceutical molecules from traditionally-claimed active plants and scientifically validating their bioactivity. This comes at a time when most pharmaceutical industries seem reluctant and/or slow to develop novel antimicrobial agents, prompting an overreliance on the limited available antibiotics. This has consequently led to the emergence of superbugs insensitive to available antibiotic regimes [<xref rid="bib71" ref-type="bibr">71</xref>, <xref rid="bib72" ref-type="bibr">72</xref>]. Flashing back to before the advent of first-generation antibiotics in 1928, humans were using and are still using herbal preparations to manage, treat, and cure various ailments. Herbal medicine thus provides a solid foundation for the discovery of new agents against these health-threatening pathogens [<xref rid="bib73" ref-type="bibr">73</xref>, <xref rid="bib74" ref-type="bibr">74</xref>].</p><p id="p0125">The current study was motivated by an ethno-based claim by the Ambeere residents and herbalists from Embu county - Kenya that, <italic>A</italic>. <italic>pluriseta</italic> root extracts are used in the management of 'strong' coughs and complicated respiratory tract infections. We hypothesized that the alluded to 'strong' cough and complicated respiratory tract infection represented TB. We therefore sought to investigate the antitubercular and general antimicrobial activities of this plant, as well as identify the bioactive compounds therein that could be responsible for the bioactivity.</p><p id="p0130">The traditional-based approach of preparing the extracts using water yielded very low antitubercular and antimicrobial activities, while the crude methanolic extract exhibited a broad-spectrum antimicrobial activity against acid-fast, Gram-positive, Gram-negative, and fungi. This could point to a possible implication of differential solubility of various plant compounds in solvents of different polarities. It is established that solvent polarity affects the qualitative and quantitative composition of bioactive compounds enriched in various solvents, and that methanol is a better and more powerful extractant compared to water [<xref rid="bib66" ref-type="bibr">66</xref>, <xref rid="bib67" ref-type="bibr">67</xref>, <xref rid="bib68" ref-type="bibr">68</xref>]. With methanolic crude extract giving a robust antitubercular activity, the next question we asked ourselves was whether solvent fractionation would give us more fractions with potent activity, and at a lower concentration (from 1 g/mL to between 50-6.25 &#x003bc;g/mL; Tables&#x000a0;<xref rid="tbl1" ref-type="table">1</xref> and <xref rid="tbl3" ref-type="table">3</xref>). Compared to the positive control, the concentration of the crude methanolic extract was 10<sup>4</sup>-fold higher. We reasoned that the active compound(s) in the crude methanolic extract comprised only a small fraction of the crude extract and if purified and isolated, might work at a lower concentration, or even more potently than the standard antibiotic used. To test this assumption, we fractionated the plant sample by organic solvents of increasing concentration. Interestingly, all solvent extract fractions had a strong antitubercular activity with MIC ranging between 25 and 6.25 &#x003bc;g/mL that yielded similar inhibitory capacity (0 GU) to the commercially available antimycobacterial drugs, streptomycin, isoniazid, rifampicin, and ethambutol (SIRE) (<xref rid="tbl3" ref-type="table">Table&#x000a0;3</xref>). These findings are consistent with other studies that have demonstrated that plants are an excellent potential source of active antitubercular compounds [<xref rid="bib18" ref-type="bibr">18</xref>, <xref rid="bib39" ref-type="bibr">39</xref>, <xref rid="bib51" ref-type="bibr">51</xref>, <xref rid="bib75" ref-type="bibr">75</xref>]. However, solvent fractionation yielded relatively lower general antimicrobial activity against Gram-positive, Gram-negative, and fungi compared to the crude extract (Tables&#x000a0;<xref rid="tbl2" ref-type="table">2</xref> and <xref rid="tbl4" ref-type="table">4</xref>). This phenomenon suggests a possible synergistic and/or additive effect of the active molecules in the crude extract, an effect that was possibly lost by fractionation [<xref rid="bib76" ref-type="bibr">76</xref>, <xref rid="bib77" ref-type="bibr">77</xref>, <xref rid="bib78" ref-type="bibr">78</xref>, <xref rid="bib79" ref-type="bibr">79</xref>]. Furthermore, the fact that fractions demonstrated a robust antitubercular activity, and low general activity against Gram-positive, Gram-negative, and fungi allude to a possible selective activity against MTB, which is an essential feature in search of novel selective antitubercular leads [<xref rid="bib69" ref-type="bibr">69</xref>, <xref rid="bib70" ref-type="bibr">70</xref>].</p><p id="p0135">Bioactivity of plant extracts is the work of secondary metabolites produced for purposes of normal plant defenses; to deter, stun, poison or kill threatening species, but inadvertently inhibiting various physiological targets/processes required for growth, biosynthesis of macromolecules, metabolism, and virulence of microbial systems [<xref rid="bib30" ref-type="bibr">30</xref>, <xref rid="bib80" ref-type="bibr">80</xref>, <xref rid="bib81" ref-type="bibr">81</xref>, <xref rid="bib82" ref-type="bibr">82</xref>]. To characterize and identify the active compounds mediating activity against the tested organisms, we initially performed qualitative phytochemical screening in all extract solvent fractions (<xref rid="tbl6" ref-type="table">Table&#x000a0;6</xref>), and subsequent GC-MS analysis of the methanolic solvent extract fraction (<xref rid="tbl7" ref-type="table">Table&#x000a0;7</xref> &#x00026; Figures&#x000a0;<xref rid="fig1" ref-type="fig">1</xref> and <xref rid="fig2" ref-type="fig">2</xref>). We qualitatively identified terpenoids, phenolics such as flavonoids and anthraquinones, and alkaloids in <italic>A.&#x000a0;pluriseta</italic> extracts, and thus speculated that they are the phytochemicals partly or wholly responsible of the antitubercular activity demonstrated by various extract fractions. Previous studies have also reported presence of terpenoids, alkaloid, flavonoids, anthraquinones and phenolic in <italic>A.&#x000a0;pluriseta</italic> aqueous extract [<xref rid="bib40" ref-type="bibr">40</xref>, <xref rid="bib47" ref-type="bibr">47</xref>, <xref rid="bib83" ref-type="bibr">83</xref>, <xref rid="bib84" ref-type="bibr">84</xref>]. Terpenes were enriched in all fractions tested, and a broad range of terpenes identified in other studies have been associated with antitubercular activity, partly due to their lipophilicity that makes it easier for them to penetrate through MTB wall [<xref rid="bib85" ref-type="bibr">85</xref>, <xref rid="bib86" ref-type="bibr">86</xref>]. Alkaloids, terpenoids, and flavonoids have been speculated to induce antitubercular activity by interfering with the MTB efflux pump, thus modulating in non-specific manner membrane proteins and receptors as well as inhibiting natural methods for MTB resistance development [<xref rid="bib87" ref-type="bibr">87</xref>].</p><p id="p0140">Additionally, using GC-MS, we identified two abundant fatty acid alkyl esters in methanolic solvent extract fraction; 2-hydroxy-1-(hydroxymethyl) ethyl ester-hexadecanoic acid (2-palmitoylglycerol) and 2,3-dihydroxypropyl ester-octadecanoic acid (glyceryl monostearate); (<xref rid="tbl7" ref-type="table">Table&#x000a0;7</xref> and Figures&#x000a0;<xref rid="fig1" ref-type="fig">1</xref> and <xref rid="fig2" ref-type="fig">2</xref>). We speculate that these fatty acid alkyl esters are associated with the observed bioactivity of this extract fraction. In fact, previous studies have reported antimicrobial and antimycobacterial activities of naturally occurring and synthetic fatty acid alkyl esters [<xref rid="bib88" ref-type="bibr">88</xref>, <xref rid="bib89" ref-type="bibr">89</xref>, <xref rid="bib90" ref-type="bibr">90</xref>, <xref rid="bib91" ref-type="bibr">91</xref>]. Although the relationship between structure and antimicrobial activity of various fatty acids and their ester derivatives remains elusive, it is speculated that the inhibitory effect is greatly influenced by the number and presence of double bonds [<xref rid="bib90" ref-type="bibr">90</xref>]. Mechanistically, fatty acids and their ester derivatives (FAED) act by interfering with the vital fatty acid synthase-I (FASI)- and FASIII-mediated fatty acid biosynthesis and degradation [<xref rid="bib92" ref-type="bibr">92</xref>]. Furthermore, FAED and long-chain alkanes, by acting as exogenous mimics of microbial cell wall and membrane fatty acid derivatives, have been suggested to interfere with the cell membrane and wall biochemistry thus inducing an antimicrobial activity [<xref rid="bib93" ref-type="bibr">93</xref>, <xref rid="bib94" ref-type="bibr">94</xref>, <xref rid="bib95" ref-type="bibr">95</xref>]. Damage to cell envelope leads to perturbation of ion homeostasis across the membrane, defective cell to cell adhesion, disturbed substrate attachment, and consequent inability to form biofilm, which is essential for tubercular pathogenicity [<xref rid="bib14" ref-type="bibr">14</xref>]. However, it is necessary to isolate individual pure compounds and test their activity individually and/or in combination. Taken together, we show that <italic>A.&#x000a0;pluriseta</italic> extract solvent fractions have robust selective antitubercular activity, and hence we provide a scientific rationalization and justification of the possible therapeutic use of <italic>A.&#x000a0;pluriseta</italic>.</p></sec><sec id="sec5"><label>5</label><title>Conclusion</title><p id="p0145">The findings from this work demonstrate that <italic>A.&#x000a0;pluriseta</italic> root extract fractions have robust selective antitubercular activity. The extract fractions, especially the ethyl acetate and methanolic fraction, provide a potential source of novel, antitubercular lead candidate(s). GC-MS analysis revealed an abundance of fatty acid esters, which we strongly associated with demonstrated antitubercular activity. Further work is required to isolate pure compounds, test their specific molecular targets, with a view of deciphering the mode(s) of action.</p></sec><sec id="sec6"><title>Declarations</title><sec id="sec6.1"><title>Author contribution statement</title><p id="p0150">S.N. Njeru and J.M. Muema: Conceived and designed the experiments; Performed the experiments; Analyzed and interpreted the data; Contributed reagents, materials, analysis tools or data; Wrote the paper.</p></sec><sec id="sec6.2"><title>Funding statement</title><p id="p0155">This study was supported by the <funding-source id="gs1"><institution-wrap><institution-id institution-id-type="doi">10.13039/100004413</institution-id><institution>International Foundation for Science</institution></institution-wrap></funding-source>, Stockholm, Sweden, through IFS grant No. F/5372-1 to Dr. Sospeter Ngoci, Njeru.</p></sec><sec id="sec6.3"><title>Competing interest statement</title><p id="p0160">The authors declare no conflict of interest.</p></sec><sec id="sec6.4"><title>Additional information</title><p id="p0165">No additional information is available for this paper.</p></sec></sec></body><back><ref-list id="cebib0010"><title>References</title><ref id="bib1"><label>1</label><element-citation publication-type="journal" id="sref1"><person-group person-group-type="author"><name><surname>Njeru</surname><given-names>S.N.</given-names></name><name><surname>Obonyo</surname><given-names>M.A.</given-names></name><name><surname>Nyambati</surname><given-names>S.O.</given-names></name><name><surname>Ngari</surname><given-names>S.M.</given-names></name></person-group><article-title>Bioactivity of Cissampelos pareira medicinal plant against Mycobacterium tuberculosis</article-title><source>J.&#x000a0;Pharmacogn. Phytochem.</source><volume>3</volume><issue>6</issue><year>2015</year></element-citation></ref><ref id="bib2"><label>2</label><element-citation publication-type="journal" id="sref2"><person-group person-group-type="author"><name><surname>Scriba</surname><given-names>T.J.</given-names></name><name><surname>Mizrahi</surname><given-names>V.</given-names></name></person-group><article-title>Renewing the fight against TB with an old vaccine</article-title><source>Cell</source><volume>180</volume><issue>5</issue><year>2020</year><fpage>829</fpage><lpage>831</lpage><pub-id pub-id-type="pmid">32142676</pub-id></element-citation></ref><ref id="bib3"><label>3</label><element-citation publication-type="book" id="sref3"><person-group person-group-type="author"><name><surname>Stelitano</surname><given-names>G.</given-names></name><name><surname>Sammartino</surname><given-names>C.</given-names></name></person-group><chapter-title>Multitargeting Compounds : A Promising Strategy to Overcome Multi-Drug Resistant Tuberculosis</chapter-title><year>2020</year><fpage>1</fpage><lpage>17</lpage></element-citation></ref><ref id="bib4"><label>4</label><element-citation publication-type="journal" id="sref4"><person-group person-group-type="author"><name><surname>Njeru</surname><given-names>S.N.</given-names></name><name><surname>Obonyo</surname><given-names>M.A.</given-names></name></person-group><article-title>Potency of extracts of selected plant species from Mbeere, Embu County-Kenya against Mycobacterium tuberculosis</article-title><source>J.&#x000a0;Med. Plants Res.</source><volume>10</volume><issue>12</issue><year>2016</year><fpage>149</fpage><lpage>157</lpage></element-citation></ref><ref id="bib5"><label>5</label><element-citation publication-type="journal" id="sref5"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Q.</given-names></name><name><surname>Boshoff</surname><given-names>H.I.M.</given-names></name><name><surname>Harrison</surname><given-names>J.R.</given-names></name><name><surname>Ray</surname><given-names>P.C.</given-names></name><name><surname>Green</surname><given-names>S.R.</given-names></name><name><surname>Wyatt</surname><given-names>P.G.</given-names></name><name><surname>Barry</surname><given-names>C.E.</given-names></name></person-group><article-title>PE/PPE proteins mediate nutrient transport across the outer membrane of <italic>Mycobacterium tuberculosis</italic></article-title><source>Science</source><volume>367</volume><issue>6482</issue><year>2020</year><fpage>1147</fpage><lpage>1151</lpage><pub-id pub-id-type="pmid">32139546</pub-id></element-citation></ref><ref id="bib6"><label>6</label><element-citation publication-type="book" id="sref6"><person-group person-group-type="author"><name><surname>WHO</surname></name></person-group><chapter-title>Global Tuberculosis Report 2019</chapter-title><year>2019</year><publisher-name>World Health Organization</publisher-name><publisher-loc>Geneva</publisher-loc><fpage>1</fpage><lpage>284</lpage><comment>Licence: CC BY-NC-SA 3.0 IGO</comment><ext-link ext-link-type="uri" xlink:href="https://apps.who.int/iris/bitstream/handle/10665/329368/9789241565714-eng.pdf.%202019" id="interref0010">https://apps.who.int/iris/bitstream/handle/10665/329368/9789241565714-eng.pdf. 2019</ext-link></element-citation></ref><ref id="bib7"><label>7</label><element-citation publication-type="journal" id="sref7"><person-group person-group-type="author"><name><surname>Gupta</surname><given-names>V.K.</given-names></name><name><surname>Kaushik</surname><given-names>A.</given-names></name><name><surname>Chauhan</surname><given-names>D.S.</given-names></name><name><surname>Ahirwar</surname><given-names>R.K.</given-names></name><name><surname>Sharma</surname><given-names>S.</given-names></name><name><surname>Bisht</surname><given-names>D.</given-names></name></person-group><article-title>Anti-mycobacterial activity of some medicinal plants used traditionally by tribes from Madhya Pradesh, India for treating tuberculosis related symptoms</article-title><source>J.&#x000a0;Ethnopharmacol.</source><volume>227</volume><year>2018</year><fpage>113</fpage><lpage>120</lpage><pub-id pub-id-type="pmid">30172059</pub-id></element-citation></ref><ref id="bib8"><label>8</label><element-citation publication-type="journal" id="sref8"><person-group person-group-type="author"><name><surname>van den Boogaard</surname><given-names>J.</given-names></name><name><surname>Slump</surname><given-names>E.</given-names></name><name><surname>Schimmel</surname><given-names>H.J.</given-names></name><name><surname>van der Hoek</surname><given-names>W.</given-names></name><name><surname>van den Hof</surname><given-names>S.</given-names></name><name><surname>de Vries</surname><given-names>G.</given-names></name></person-group><article-title>High incidence of active tuberculosis in asylum seekers from Eritrea and Somalia in the first 5 years after arrival in The Netherlands</article-title><source>Emerg. Infect. Dis.</source><volume>26</volume><issue>4</issue><year>2020</year><fpage>675</fpage><lpage>681</lpage><pub-id pub-id-type="pmid">32186488</pub-id></element-citation></ref><ref id="bib9"><label>9</label><element-citation publication-type="journal" id="sref9"><person-group person-group-type="author"><name><surname>Williams</surname><given-names>R.J.</given-names></name></person-group><article-title>Globalization of antimicrobial resistance: epidemiological challenges</article-title><source>Clin. Infect. Dis. : Off. Publ. Infect. Dis. Soc. Am.</source><volume>33</volume><issue>Suppl 3</issue><year>2001</year><fpage>S116</fpage><lpage>S117</lpage></element-citation></ref><ref id="bib10"><label>10</label><element-citation publication-type="journal" id="sref10"><person-group person-group-type="author"><name><surname>Levy</surname><given-names>S.B.</given-names></name><name><surname>Marshall</surname><given-names>B.</given-names></name></person-group><article-title>Antibacterial resistance worldwide: causes, challenges and responses</article-title><source>Nat. Med.</source><volume>10</volume><year>2004</year><fpage>S122</fpage><lpage>S129</lpage><pub-id pub-id-type="pmid">15577930</pub-id></element-citation></ref><ref id="bib11"><label>11</label><element-citation publication-type="journal" id="sref11"><person-group person-group-type="author"><name><surname>Reid</surname><given-names>M.J.A.</given-names></name><name><surname>Goosby</surname><given-names>E.</given-names></name></person-group><article-title>Improving quality is necessary to building a TB-free world: lancet Commission on Tuberculosis</article-title><source>J.&#x000a0;Clin. Tuber. Other Mycobact. Dis.</source><volume>19</volume><year>2020</year><fpage>100156</fpage><comment>100156</comment></element-citation></ref><ref id="bib12"><label>12</label><element-citation publication-type="journal" id="sref12"><person-group person-group-type="author"><name><surname>Bibi</surname><given-names>Y.</given-names></name><name><surname>Nisa</surname><given-names>S.</given-names></name><name><surname>Chaudhary</surname><given-names>F.M.</given-names></name><name><surname>Zia</surname><given-names>M.</given-names></name></person-group><article-title>Antibacterial activity of some selected medicinal plants of Pakistan</article-title><source>BMC Compl. Alternative Med.</source><volume>11</volume><issue>1</issue><year>2011</year><fpage>52</fpage></element-citation></ref><ref id="bib13"><label>13</label><element-citation publication-type="journal" id="sref13"><person-group person-group-type="author"><name><surname>Njeru</surname><given-names>S.N.</given-names></name><name><surname>Obonyo</surname><given-names>M.</given-names></name><name><surname>Nyambati</surname><given-names>S.</given-names></name><name><surname>Ngari</surname><given-names>S.</given-names></name><name><surname>Mwakubambanya</surname><given-names>R.</given-names></name><name><surname>Mavura</surname><given-names>H.</given-names></name></person-group><article-title>Antimicrobial and cytotoxicity properties of the organic solvent fractions of Clerodendrum myricoides (Hochst.) R. Br. ex Vatke: Kenyan traditional medicinal plant</article-title><source>J.&#x000a0;Intercult. Ethnopharmacol.</source><volume>5</volume><issue>3</issue><year>2016</year></element-citation></ref><ref id="bib14"><label>14</label><element-citation publication-type="journal" id="sref14"><person-group person-group-type="author"><name><surname>Mukherjee</surname><given-names>K.</given-names></name><name><surname>Tribedi</surname><given-names>P.</given-names></name><name><surname>Mukhopadhyay</surname><given-names>B.</given-names></name><name><surname>Sil</surname><given-names>A.K.</given-names></name></person-group><article-title>Antibacterial activity of long-chain fatty alcohols against mycobacteria</article-title><source>FEMS (Fed. Eur. Microbiol. Soc.) Microbiol. Lett.</source><volume>338</volume><issue>2</issue><year>2013</year><fpage>177</fpage><lpage>183</lpage></element-citation></ref><ref id="bib15"><label>15</label><element-citation publication-type="journal" id="sref15"><person-group person-group-type="author"><name><surname>Lewis</surname><given-names>K.</given-names></name><name><surname>Ausubel</surname><given-names>F.M.</given-names></name></person-group><article-title>Prospects for plant-derived antibacterials</article-title><source>Nat. Biotechnol.</source><volume>24</volume><issue>12</issue><year>2006</year><fpage>1504</fpage><lpage>1507</lpage><pub-id pub-id-type="pmid">17160050</pub-id></element-citation></ref><ref id="bib16"><label>16</label><element-citation publication-type="journal" id="sref16"><person-group person-group-type="author"><name><surname>Abreu</surname><given-names>A.C.</given-names></name><name><surname>McBain</surname><given-names>A.J.</given-names></name><name><surname>Simoes</surname><given-names>M.</given-names></name></person-group><article-title>Plants as sources of new antimicrobials and resistance-modifying agents</article-title><source>Nat. Prod. Rep.</source><volume>29</volume><issue>9</issue><year>2012</year><fpage>1007</fpage><lpage>1021</lpage><pub-id pub-id-type="pmid">22786554</pub-id></element-citation></ref><ref id="bib17"><label>17</label><element-citation publication-type="journal" id="sref17"><person-group person-group-type="author"><name><surname>Alian</surname><given-names>A.D.</given-names></name><name><surname>Nyegue</surname><given-names>M.A.</given-names></name><name><surname>Djova</surname><given-names>S.V.</given-names></name><name><surname>Etoa</surname><given-names>F.-X.</given-names></name></person-group><article-title>Genotoxicity of Dissotis Multiflora (Sm) Triana (Melastomataceae) and Paullinia Pinnata Linn (Sapindaceae)</article-title><source>J. Trop. Med.</source><year>2020</year><fpage>2020</fpage></element-citation></ref><ref id="bib18"><label>18</label><element-citation publication-type="journal" id="sref18"><person-group person-group-type="author"><name><surname>Mir</surname><given-names>M.A.</given-names></name><name><surname>Bashir</surname><given-names>N.</given-names></name><name><surname>Alfaify</surname><given-names>A.</given-names></name><name><surname>Oteef</surname><given-names>M.D.Y.</given-names></name></person-group><article-title>GC-MS analysis of Myrtus communis extract and its antibacterial activity against Gram- positive bacteria</article-title><source>BMC Complement. Med. Ther.</source><volume>3</volume><year>2020</year><fpage>1</fpage><lpage>9</lpage></element-citation></ref><ref id="bib19"><label>19</label><element-citation publication-type="journal" id="sref19"><person-group person-group-type="author"><name><surname>Kuete</surname><given-names>V.</given-names></name></person-group><article-title>Potential of Cameroonian plants and derived products against microbial infections: a review</article-title><source>Planta Med.</source><year>2010</year><fpage>1479</fpage><lpage>1491</lpage><pub-id pub-id-type="pmid">20533165</pub-id></element-citation></ref><ref id="bib20"><label>20</label><element-citation publication-type="journal" id="sref20"><person-group person-group-type="author"><name><surname>Batiha</surname><given-names>G.E.-s.</given-names></name><name><surname>Beshbishy</surname><given-names>A.M.</given-names></name><name><surname>Alkazmi</surname><given-names>L.</given-names></name><name><surname>Adeyemi</surname><given-names>O.S.</given-names></name><name><surname>Nadwa</surname><given-names>E.</given-names></name><name><surname>Rashwan</surname><given-names>E.</given-names></name><name><surname>El-mleeh</surname><given-names>A.</given-names></name><name><surname>Igarashi</surname><given-names>I.</given-names></name></person-group><article-title>Gas chromatography-mass spectrometry analysis , phytochemical screening and antiprotozoal effects of the methanolic Viola tricolor and acetonic Laurus nobilis extracts</article-title><source>BMC Compl. Med. Ther.</source><volume>2</volume><year>2020</year><fpage>1</fpage><lpage>14</lpage></element-citation></ref><ref id="bib21"><label>21</label><element-citation publication-type="journal" id="sref21"><person-group person-group-type="author"><name><surname>Cragg</surname><given-names>G.M.</given-names></name><name><surname>Newman</surname><given-names>D.J.</given-names></name></person-group><article-title>Natural products: a continuing source of novel drug leads</article-title><source>Biochim. Biophys. Acta Gen. Subj.</source><volume>1830</volume><issue>6</issue><year>2013</year><fpage>3670</fpage><lpage>3695</lpage></element-citation></ref><ref id="bib22"><label>22</label><element-citation publication-type="journal" id="sref22"><person-group person-group-type="author"><name><surname>Ahmed</surname><given-names>N.</given-names></name><name><surname>Mahmood</surname><given-names>A.</given-names></name><name><surname>Ashraf</surname><given-names>A.</given-names></name><name><surname>Bano</surname><given-names>A.</given-names></name><name><surname>Tahir</surname><given-names>S.S.</given-names></name><name><surname>Mahmood</surname><given-names>A.</given-names></name></person-group><article-title>Ethnopharmacological relevance of indigenous medicinal plants from district Bahawalnagar, Punjab, Pakistan</article-title><source>J.&#x000a0;Ethnopharmacol.</source><volume>175</volume><year>2015</year><fpage>109</fpage><lpage>123</lpage><pub-id pub-id-type="pmid">26283472</pub-id></element-citation></ref><ref id="bib23"><label>23</label><element-citation publication-type="journal" id="sref23"><person-group person-group-type="author"><name><surname>Ashraf</surname><given-names>A.</given-names></name><name><surname>Sarfraz</surname><given-names>R.A.</given-names></name><name><surname>Mahmood</surname><given-names>A.</given-names></name><name><surname>Din</surname><given-names>M.u.</given-names></name></person-group><article-title>Chemical composition and in vitro antioxidant and antitumor activities of Eucalyptus camaldulensis Dehn. leaves</article-title><source>Ind. Crop. Prod.</source><volume>74</volume><year>2015</year><fpage>241</fpage><lpage>248</lpage></element-citation></ref><ref id="bib24"><label>24</label><element-citation publication-type="journal" id="sref24"><person-group person-group-type="author"><name><surname>Ashraf</surname><given-names>A.</given-names></name><name><surname>Sarfraz</surname><given-names>R.A.</given-names></name><name><surname>Rashid</surname><given-names>M.A.</given-names></name><name><surname>Mahmood</surname><given-names>A.</given-names></name><name><surname>Shahid</surname><given-names>M.</given-names></name><name><surname>Noor</surname><given-names>N.</given-names></name></person-group><article-title>Chemical composition, antioxidant, antitumor, anticancer and cytotoxic effects of Psidium guajava leaf extracts</article-title><source>Pharmaceut. Biol.</source><volume>209</volume><issue>February</issue><year>2016</year><fpage>1</fpage><lpage>11</lpage></element-citation></ref><ref id="bib25"><label>25</label><element-citation publication-type="journal" id="sref25"><person-group person-group-type="author"><name><surname>Beshbishy</surname><given-names>A.M.</given-names></name><name><surname>Batiha</surname><given-names>G.E.-s.</given-names></name><name><surname>Adeyemi</surname><given-names>O.S.</given-names></name><name><surname>Igarashi</surname><given-names>I.</given-names></name></person-group><article-title>Inhibitory effects of methanolic Olea europaea and acetonic Acacia laeta on growth of Babesia and Theileria</article-title><source>Asian Pac. J. Trop. Med.</source><volume>12</volume><issue>9</issue><year>2019</year><fpage>425</fpage><lpage>434</lpage></element-citation></ref><ref id="bib26"><label>26</label><element-citation publication-type="journal" id="sref26"><person-group person-group-type="author"><name><surname>Kamatenesi-Mugisha</surname><given-names>M.</given-names></name><name><surname>Oryem-Origa</surname><given-names>H.</given-names></name><name><surname>Odyek</surname><given-names>O.</given-names></name><name><surname>Makawiti</surname><given-names>D.W.</given-names></name></person-group><article-title>Medicinal plants used in the treatment of fungal and bacterial infections in and around Queen Elizabeth Biosphere Reserve, western Uganda</article-title><source>Afr. J. Ecol.</source><volume>46</volume><year>2008</year><fpage>90</fpage><lpage>97</lpage></element-citation></ref><ref id="bib27"><label>27</label><element-citation publication-type="journal" id="sref27"><person-group person-group-type="author"><name><surname>Ekor</surname><given-names>M.</given-names></name></person-group><article-title>The growing use of herbal medicines : issues relating to adverse reactions and challenges in monitoring safety</article-title><source>Front. Pharmacol.</source><volume>4</volume><issue>January</issue><year>2014</year><fpage>1</fpage><lpage>10</lpage></element-citation></ref><ref id="bib28"><label>28</label><element-citation publication-type="journal" id="sref28"><person-group person-group-type="author"><name><surname>Qureshi</surname><given-names>R.</given-names></name><name><surname>Ghazanfar</surname><given-names>S.A.</given-names></name><name><surname>Obied</surname><given-names>H.</given-names></name><name><surname>Vasileva</surname><given-names>V.</given-names></name><name><surname>Tariq</surname><given-names>M.A.</given-names></name></person-group><article-title>Ethnobotany: a living science for alleviating human suffering</article-title><source>Evid. base Compl. Alternative Med.</source><volume>2016</volume><year>2016</year><fpage>10</fpage><lpage>13</lpage></element-citation></ref><ref id="bib29"><label>29</label><element-citation publication-type="journal" id="sref29"><person-group person-group-type="author"><name><surname>Tugume</surname><given-names>P.</given-names></name><name><surname>Nyakoojo</surname><given-names>C.</given-names></name></person-group><article-title>Ethno-pharmacological survey of herbal remedies used in the treatment of paediatric diseases in Buhunga parish, Rukungiri District, Uganda</article-title><source>BMC Compl. Alternative Med.</source><volume>19</volume><issue>1</issue><year>2019</year><fpage>1</fpage><lpage>10</lpage></element-citation></ref><ref id="bib30"><label>30</label><element-citation publication-type="journal" id="sref30"><person-group person-group-type="author"><name><surname>Makhafola</surname><given-names>T.J.</given-names></name><name><surname>McGaw</surname><given-names>L.J.</given-names></name><name><surname>Eloff</surname><given-names>J.N.</given-names></name></person-group><article-title>In vitro cytotoxicity and genotoxicity of five Ochna species (Ochnaceae) with excellent antibacterial activity</article-title><source>South Afr. J. Bot.</source><volume>91</volume><year>2014</year><fpage>9</fpage><lpage>13</lpage></element-citation></ref><ref id="bib31"><label>31</label><element-citation publication-type="journal" id="sref31"><person-group person-group-type="author"><name><surname>Zirihi</surname><given-names>G.N.</given-names></name><name><surname>Mambu</surname><given-names>L.</given-names></name><name><surname>Bodo</surname><given-names>B.</given-names></name><name><surname>Grellier</surname><given-names>P.</given-names></name></person-group><article-title>In vitro antiplasmodial activity and cytotoxicity of 33 West African plants used for treatment of malaria</article-title><source>J.&#x000a0;Ethnopharmacol.</source><volume>98</volume><year>2005</year><fpage>281</fpage><lpage>285</lpage><pub-id pub-id-type="pmid">15814260</pub-id></element-citation></ref><ref id="bib32"><label>32</label><element-citation publication-type="book" id="sref32"><person-group person-group-type="author"><name><surname>Stefanovi&#x00107;</surname><given-names>O.</given-names></name><name><surname>Radojevi&#x00107;</surname><given-names>I.</given-names></name><name><surname>Vasi&#x00107;</surname><given-names>S.</given-names></name><name><surname>&#x0010c;omi&#x00107;</surname><given-names>L.</given-names></name></person-group><chapter-title>Antibacterial Activity of Naturally Occurring Compounds from Selected Plants</chapter-title><year>2005</year><publisher-name>The American Phytopathological Society</publisher-name><fpage>1</fpage><lpage>24</lpage></element-citation></ref><ref id="bib33"><label>33</label><element-citation publication-type="journal" id="sref33"><person-group person-group-type="author"><name><surname>Abdallah</surname><given-names>E.M.</given-names></name></person-group><article-title>Plants: an alternative source for antimicrobials</article-title><source>J.&#x000a0;Appl. Pharmaceut. Sci.</source><volume>1</volume><issue>6</issue><year>2011</year><fpage>16</fpage><lpage>20</lpage></element-citation></ref><ref id="bib34"><label>34</label><element-citation publication-type="journal" id="sref34"><person-group person-group-type="author"><name><surname>Khameneh</surname><given-names>B.</given-names></name><name><surname>Iranshahy</surname><given-names>M.</given-names></name><name><surname>Soheili</surname><given-names>V.</given-names></name><name><surname>Fazly Bazzaz</surname><given-names>B.S.</given-names></name></person-group><article-title>Review on plant antimicrobials: a mechanistic viewpoint</article-title><source>Antimicrob. Resist. Infect. Contr.</source><volume>8</volume><issue>1</issue><year>2019</year></element-citation></ref><ref id="bib35"><label>35</label><element-citation publication-type="journal" id="sref35"><person-group person-group-type="author"><name><surname>Vijayarathna</surname><given-names>S.</given-names></name><name><surname>Sasidharan</surname><given-names>S.</given-names></name></person-group><article-title>Cytotoxicity of methanol extracts of Elaeis guineensis on MCF-7 and Vero cell lines</article-title><source>Asian Pac. J. Trop. Biomed.</source><volume>2</volume><issue>10</issue><year>2012</year><fpage>826</fpage><lpage>829</lpage><pub-id pub-id-type="pmid">23569855</pub-id></element-citation></ref><ref id="bib36"><label>36</label><element-citation publication-type="journal" id="sref36"><person-group person-group-type="author"><name><surname>Njeru</surname><given-names>S.N.</given-names></name><name><surname>Obonyo</surname><given-names>M.A.</given-names></name><name><surname>Nyambati</surname><given-names>S.O.</given-names></name><name><surname>Ngari</surname><given-names>S.M.</given-names></name></person-group><article-title>Antimicrobial and cytotoxicity properties of the crude extracts and fractions of Premna resinosa (Hochst.) Schauer (Compositae): Kenyan traditional medicinal plant</article-title><source>BMC Compl. Alternative Med.</source><volume>15</volume><issue>January</issue><year>2015</year><fpage>295</fpage><comment>295</comment></element-citation></ref><ref id="bib37"><label>37</label><element-citation publication-type="journal" id="sref37"><person-group person-group-type="author"><name><surname>Sibanda</surname><given-names>T.</given-names></name><name><surname>Okoh</surname><given-names>A.I.</given-names></name></person-group><article-title>The challenges of overcoming antibiotic resistance: plant extracts as potential sources of antimicrobial and resistance modifying agents</article-title><source>Afr. J. Biotechnol.</source><volume>6</volume><issue>25</issue><year>2007</year></element-citation></ref><ref id="bib38"><label>38</label><element-citation publication-type="journal" id="sref38"><person-group person-group-type="author"><name><surname>Cordell</surname><given-names>G.A.</given-names></name><name><surname>Colvard</surname><given-names>M.D.</given-names></name></person-group><article-title>Natural products and traditional medicine: turning on a paradigm</article-title><source>J.&#x000a0;Nat. Prod.</source><volume>75</volume><issue>3</issue><year>2012</year><fpage>514</fpage><lpage>525</lpage><pub-id pub-id-type="pmid">22233451</pub-id></element-citation></ref><ref id="bib39"><label>39</label><element-citation publication-type="journal" id="sref39"><person-group person-group-type="author"><name><surname>Mongalo</surname><given-names>N.I.</given-names></name><name><surname>McGaw</surname><given-names>L.J.</given-names></name><name><surname>Finnie</surname><given-names>J.F.</given-names></name><name><surname>Van Staden</surname><given-names>J.</given-names></name></person-group><article-title>Pharmacological properties of extracts from six South African medicinal plants used to treat sexually transmitted infections (STIs) and related infections</article-title><source>South Afr. J. Bot.</source><year>2017</year></element-citation></ref><ref id="bib40"><label>40</label><element-citation publication-type="journal" id="sref40"><person-group person-group-type="author"><name><surname>Yaouba</surname><given-names>S.</given-names></name><name><surname>Valkonen</surname><given-names>A.</given-names></name><name><surname>Coghi</surname><given-names>P.</given-names></name><name><surname>Gao</surname><given-names>J.</given-names></name><name><surname>Guantai</surname><given-names>E.M.</given-names></name><name><surname>Derese</surname><given-names>S.</given-names></name><name><surname>Wong</surname><given-names>V.K.W.</given-names></name><name><surname>Erd&#x000e9;lyi</surname><given-names>M.</given-names></name><name><surname>Yenesew</surname><given-names>A.</given-names></name></person-group><article-title>Crystal structures and cytotoxicity of ent-kaurane-type diterpenoids from two Aspilia species</article-title><source>Molecules</source><volume>23</volume><issue>12</issue><year>2018</year><fpage>1</fpage><lpage>13</lpage></element-citation></ref><ref id="bib41"><label>41</label><element-citation publication-type="journal" id="sref41"><person-group person-group-type="author"><name><surname>Gachathi</surname><given-names>F.N.</given-names></name></person-group><article-title>Kikuyu botanical dictionary: a guide to plant names, uses and cultural values</article-title><source>Trop. Bot.</source><year>2007</year></element-citation></ref><ref id="bib42"><label>42</label><element-citation publication-type="journal" id="sref42"><person-group person-group-type="author"><name><surname>Cos</surname><given-names>P.</given-names></name><name><surname>Hermans</surname><given-names>N.</given-names></name><name><surname>De Bruyne</surname><given-names>T.</given-names></name><name><surname>Apers</surname><given-names>S.</given-names></name><name><surname>Sindambiwe</surname><given-names>J.B.</given-names></name><name><surname>Witvrouw</surname><given-names>M.</given-names></name><name><surname>De Clercq</surname><given-names>E.</given-names></name><name><surname>Berghe</surname><given-names>D.V.</given-names></name><name><surname>Pieters</surname><given-names>L.</given-names></name><name><surname>Vlietinck</surname><given-names>A.J.</given-names></name></person-group><article-title>Antiviral activity of Rwandan medicinal plants against human immunodeficiency virus type-1 (HIV-1)</article-title><source>Phytomedicine</source><volume>9</volume><issue>1</issue><year>2002</year><fpage>62</fpage><lpage>68</lpage><pub-id pub-id-type="pmid">11924766</pub-id></element-citation></ref><ref id="bib43"><label>43</label><element-citation publication-type="journal" id="sref43"><person-group person-group-type="author"><name><surname>Njoroge</surname><given-names>G.N.</given-names></name><name><surname>Bussmann</surname><given-names>R.W.</given-names></name></person-group><article-title>Traditional management of ear, nose and throat (ENT) diseases in Central Kenya</article-title><source>J.&#x000a0;Ethnobiol. Ethnomed.</source><volume>2</volume><issue>1</issue><year>2006</year><fpage>1</fpage><comment>1</comment><pub-id pub-id-type="pmid">16393342</pub-id></element-citation></ref><ref id="bib44"><label>44</label><element-citation publication-type="journal" id="sref44"><person-group person-group-type="author"><name><surname>Njoroge</surname><given-names>G.N.</given-names></name><name><surname>Bussmann</surname><given-names>R.W.</given-names></name></person-group><article-title>Ethnotherapeautic management of skin diseases among the Kikuyus of Central Kenya</article-title><source>J.&#x000a0;Ethnopharmacol.</source><volume>111</volume><issue>2</issue><year>2007</year><fpage>303</fpage><lpage>307</lpage><pub-id pub-id-type="pmid">17207950</pub-id></element-citation></ref><ref id="bib45"><label>45</label><element-citation publication-type="journal" id="sref45"><person-group person-group-type="author"><name><surname>Piero</surname><given-names>N.M.</given-names></name><name><surname>Joan</surname><given-names>M.N.</given-names></name><name><surname>Cromwell</surname><given-names>K.M.</given-names></name><name><surname>Joseph</surname><given-names>N.J.</given-names></name><name><surname>Wilson</surname><given-names>N.M.</given-names></name><name><surname>Daniel</surname><given-names>M.</given-names></name><name><surname>Peter</surname><given-names>G.K.</given-names></name><name><surname>Eliud</surname><given-names>N.N.</given-names></name></person-group><article-title>Hypoglycemic activity of some kenyan plants traditionally used to manage diabetes mellitus in Eastern Province</article-title><source>J.&#x000a0;Diabetes Metabol.</source><volume>2</volume><issue>8</issue><year>2011</year></element-citation></ref><ref id="bib46"><label>46</label><element-citation publication-type="journal" id="sref46"><person-group person-group-type="author"><name><surname>Kuria</surname><given-names>J.M.</given-names></name><name><surname>Mbaria</surname><given-names>J.M.</given-names></name><name><surname>Gathumbi</surname><given-names>P.K.</given-names></name><name><surname>Kiama</surname><given-names>S.G.</given-names></name></person-group><article-title>Influence of Aspilia pluriseta Schweinf ( Asteraceae ) on the healing of dermal excision wounds ( mouse model ) and skin sensitization activity ( Guinea pig model )</article-title><source>Afr. J. Pharmcol. Ther.</source><volume>4</volume><issue>3</issue><year>2015</year><fpage>112</fpage><lpage>117</lpage></element-citation></ref><ref id="bib47"><label>47</label><element-citation publication-type="journal" id="sref47"><person-group person-group-type="author"><name><surname>Sebisubi</surname><given-names>F.M.</given-names></name><name><surname>Odyek</surname><given-names>O.</given-names></name><name><surname>Anokbonggo</surname><given-names>W.W.</given-names></name><name><surname>Ogwal-Okeng</surname><given-names>J.</given-names></name><name><surname>Carcache-Blanco</surname><given-names>E.J.</given-names></name><name><surname>Ma</surname><given-names>C.</given-names></name><name><surname>Orjala</surname><given-names>J.</given-names></name><name><surname>Tan</surname><given-names>G.T.</given-names></name></person-group><article-title>Antimalarial activity of Aspilia pruliseta, a medicinal plant from Uganda</article-title><source>Planta Med.</source><volume>76</volume><issue>16</issue><year>2010</year><fpage>1870</fpage><lpage>1873</lpage><pub-id pub-id-type="pmid">20539972</pub-id></element-citation></ref><ref id="bib48"><label>48</label><element-citation publication-type="journal" id="sref48"><person-group person-group-type="author"><name><surname>Mwonga</surname><given-names>K.B.</given-names></name><name><surname>Mwaniki</surname><given-names>E.</given-names></name><name><surname>Dorcas</surname><given-names>Y.S.</given-names></name><name><surname>Piero</surname><given-names>N.M.</given-names></name></person-group><article-title>Molluscicidal effects of aqueous extracts of selected medicinal plants</article-title><source>Pharm. Anal. Acta</source><volume>6</volume><issue>11</issue><year>2015</year></element-citation></ref><ref id="bib49"><label>49</label><element-citation publication-type="journal" id="sref49"><person-group person-group-type="author"><name><surname>Cos</surname><given-names>P.</given-names></name><name><surname>Hermans</surname><given-names>N.</given-names></name><name><surname>Van Poel</surname><given-names>B.</given-names></name><name><surname>De Bruyne</surname><given-names>T.</given-names></name><name><surname>Apers</surname><given-names>S.</given-names></name><name><surname>Sindambiwe</surname><given-names>J.B.</given-names></name><name><surname>Vanden Berghe</surname><given-names>D.</given-names></name><name><surname>Pieters</surname><given-names>L.</given-names></name><name><surname>Vlietinck</surname><given-names>A.J.</given-names></name></person-group><article-title>Complement modulating activity of Rwandan medicinal plants</article-title><source>Phytomedicine</source><volume>9</volume><issue>1</issue><year>2002</year><fpage>56</fpage><lpage>61</lpage><pub-id pub-id-type="pmid">11924765</pub-id></element-citation></ref><ref id="bib50"><label>50</label><element-citation publication-type="journal" id="sref50"><person-group person-group-type="author"><name><surname>Njonge</surname><given-names>F.K.</given-names></name><name><surname>Mutugi</surname><given-names>M.</given-names></name><name><surname>Kareru</surname><given-names>P.G.</given-names></name><name><surname>Githigia</surname><given-names>S.M.</given-names></name><name><surname>Waihenya</surname><given-names>R.</given-names></name><name><surname>Nyakundi</surname><given-names>W.O.</given-names></name></person-group><article-title>Assessment of herbal anthelmintics used by the farmers in Kirinyaga County, Kenya, for the treatment of helminthiosis in cattle</article-title><source>Arf. J. Pharm. Pharmcol.</source><volume>7</volume><issue>29</issue><year>2013</year><fpage>2100</fpage><lpage>2104</lpage></element-citation></ref><ref id="bib51"><label>51</label><element-citation publication-type="journal" id="sref51"><person-group person-group-type="author"><name><surname>Munster</surname><given-names>W.B.</given-names></name><name><surname>Dusseldorf</surname><given-names>R.B.</given-names></name><name><surname>Franz</surname><given-names>G.</given-names></name><name><surname>Zurich</surname><given-names>O.S.</given-names></name><name><surname>Herz</surname><given-names>W.</given-names></name><name><surname>Zurich</surname><given-names>M.H.</given-names></name><name><surname>Lausanne</surname><given-names>K.H.</given-names></name><name><surname>Gif-sur-yvette</surname><given-names>P.P.</given-names></name><name><surname>Tyler</surname><given-names>Y.E.</given-names></name><name><surname>Lafayette</surname><given-names>W.</given-names></name><name><surname>Amsterdam</surname><given-names>P.a.V.Z.</given-names></name><name><surname>Cantreil</surname><given-names>C.L.</given-names></name><name><surname>Franzblau</surname><given-names>S.G.</given-names></name><name><surname>Fischer</surname><given-names>N.H.</given-names></name></person-group><article-title>Antimycobacterial plant terpenoids</article-title><source>Planta Med.</source><volume>67</volume><year>2001</year><fpage>685</fpage><lpage>694</lpage><pub-id pub-id-type="pmid">11731906</pub-id></element-citation></ref><ref id="bib52"><label>52</label><element-citation publication-type="book" id="sref52"><person-group person-group-type="author"><name><surname>Riley</surname><given-names>B.W.</given-names></name><name><surname>Brokensha</surname><given-names>D.</given-names></name></person-group><chapter-title>The Mbeere in Kenya; Botanical Identity and Use Vol (Ii)</chapter-title><year>1988</year><publisher-name>University press of America</publisher-name><publisher-loc>USA</publisher-loc></element-citation></ref><ref id="bib53"><label>53</label><element-citation publication-type="journal" id="sref53"><person-group person-group-type="author"><name><surname>Mariita</surname><given-names>R.</given-names></name><name><surname>Ogol</surname><given-names>C.</given-names></name><name><surname>Oguge</surname><given-names>N.</given-names></name><name><surname>Okemo</surname><given-names>P.</given-names></name></person-group><article-title>Antitubercular and phytochemical investigation of methanol extracts of medicinal plants used by the Samburu community in Kenya</article-title><source>Trop. J. Pharmaceut. Res.</source><volume>9</volume><issue>4</issue><year>2010</year></element-citation></ref><ref id="bib54"><label>54</label><element-citation publication-type="journal" id="sref54"><person-group person-group-type="author"><name><surname>Gupta</surname><given-names>V.K.</given-names></name><name><surname>Shukla</surname><given-names>C.</given-names></name><name><surname>Bisht</surname><given-names>G.R.S.</given-names></name><name><surname>Saikia</surname><given-names>D.</given-names></name><name><surname>Kumar</surname><given-names>S.</given-names></name><name><surname>Thakur</surname><given-names>R.L.</given-names></name></person-group><article-title>Detection of anti-tuberculosis activity in some folklore plants by radiometric BACTEC assay</article-title><source>Lett. Appl. Microbiol.</source><volume>52</volume><issue>1</issue><year>2011</year><fpage>33</fpage><lpage>40</lpage><pub-id pub-id-type="pmid">21114505</pub-id></element-citation></ref><ref id="bib55"><label>55</label><element-citation publication-type="journal" id="sref55"><person-group person-group-type="author"><name><surname>Gallo</surname><given-names>J.F.</given-names></name><name><surname>Pinhata</surname><given-names>J.M.W.</given-names></name><name><surname>Saraceni</surname><given-names>C.P.</given-names></name><name><surname>de Oliveira</surname><given-names>R.S.</given-names></name></person-group><article-title>Evaluation of the BACTEC MGIT 960 system and the resazurin microtiter assay for susceptibility testing of Mycobacterium tuberculosis to second-line drugs</article-title><source>J.&#x000a0;Microbiol. Methods</source><volume>139</volume><issue>May</issue><year>2017</year><fpage>168</fpage><lpage>171</lpage><pub-id pub-id-type="pmid">28601653</pub-id></element-citation></ref><ref id="bib56"><label>56</label><element-citation publication-type="journal" id="sref56"><person-group person-group-type="author"><name><surname>Adami</surname><given-names>A.G.</given-names></name><name><surname>Gallo</surname><given-names>J.F.</given-names></name><name><surname>Pinhata</surname><given-names>J.M.W.</given-names></name><name><surname>Martins</surname><given-names>M.C.</given-names></name><name><surname>Giampaglia</surname><given-names>C.M.S.</given-names></name><name><surname>de Oliveira</surname><given-names>R.S.</given-names></name></person-group><article-title>Modified protocol for drug susceptibility testing of MGIT cultures of Mycobacterium tuberculosis by the MGIT 960</article-title><source>Diagn. Microbiol. Infect. Dis.</source><volume>87</volume><issue>2</issue><year>2017</year><fpage>108</fpage><lpage>111</lpage><pub-id pub-id-type="pmid">27889251</pub-id></element-citation></ref><ref id="bib57"><label>57</label><element-citation publication-type="journal" id="sref57"><person-group person-group-type="author"><name><surname>Yalcin</surname><given-names>D.</given-names></name><name><surname>T&#x000fc;rk</surname><given-names>K.H.</given-names></name><name><surname>&#x000d6;zer</surname><given-names>T.</given-names></name></person-group><article-title>Evaluation of phytotherapeutic activities and phytochemical content of Phormidium autumnale Gomont from natural freshwater sources</article-title><source>Environ. Monit. Assess.</source><volume>192</volume><year>2020</year></element-citation></ref><ref id="bib58"><label>58</label><element-citation publication-type="book" id="sref58"><person-group person-group-type="author"><name><surname>Wayne</surname><given-names>P.A.</given-names></name></person-group><series>Clinical and Laboratory Standards institute</series><volume>17</volume><year>2007</year><publisher-name>Performance standards for antimicrobial susceptibility testing</publisher-name></element-citation></ref><ref id="bib59"><label>59</label><element-citation publication-type="journal" id="sref59"><person-group person-group-type="author"><name><surname>Mbaveng</surname><given-names>A.T.</given-names></name><name><surname>Ngameni</surname><given-names>B.</given-names></name><name><surname>Kuete</surname><given-names>V.</given-names></name><name><surname>Simo</surname><given-names>I.K.</given-names></name><name><surname>Ambassa</surname><given-names>P.</given-names></name><name><surname>Roy</surname><given-names>R.</given-names></name><name><surname>Bezabih</surname><given-names>M.</given-names></name><name><surname>Etoa</surname><given-names>F.-X.</given-names></name><name><surname>Ngadjui</surname><given-names>B.T.</given-names></name><name><surname>Abegaz</surname><given-names>B.M.</given-names></name></person-group><article-title>Antimicrobial activity of the crude extracts and five flavonoids from the twigs of Dorstenia barteri (Moraceae)</article-title><source>J.&#x000a0;Ethnopharmacol.</source><volume>116</volume><issue>3</issue><year>2008</year><fpage>483</fpage><lpage>489</lpage><pub-id pub-id-type="pmid">18280679</pub-id></element-citation></ref><ref id="bib60"><label>60</label><element-citation publication-type="journal" id="sref60"><person-group person-group-type="author"><name><surname>Naeim</surname><given-names>H.</given-names></name><name><surname>El-hawiet</surname><given-names>A.</given-names></name><name><surname>Rahman</surname><given-names>R.A.A.</given-names></name><name><surname>Hussein</surname><given-names>A.</given-names></name><name><surname>Demellawy</surname><given-names>M.A.E.</given-names></name><name><surname>Embaby</surname><given-names>A.M.</given-names></name></person-group><article-title>Antibacterial activity of Centaurea pumilio L. root and aerial part extracts against some multidrug resistant bacteria</article-title><source>BMC Complement. Med. Ther.</source><year>2020</year><fpage>1</fpage><lpage>13</lpage><pub-id pub-id-type="pmid">32020859</pub-id></element-citation></ref><ref id="bib61"><label>61</label><element-citation publication-type="journal" id="sref61"><person-group person-group-type="author"><name><surname>Zawawi</surname><given-names>N.Z.M.</given-names></name><name><surname>Shaari</surname><given-names>R.</given-names></name><name><surname>Nordin</surname><given-names>M.L.</given-names></name><name><surname>Hamdan</surname><given-names>R.H.</given-names></name><name><surname>Peng</surname><given-names>T.L.</given-names></name><name><surname>Zalati</surname><given-names>C.W.S.C.W.</given-names></name></person-group><article-title>Antibacterial and cytotoxic activity assessment of Channa striatus (Haruan) extract</article-title><source>Veter. World</source><volume>13</volume><year>2020</year><fpage>508</fpage><lpage>514</lpage></element-citation></ref><ref id="bib62"><label>62</label><element-citation publication-type="journal" id="sref62"><person-group person-group-type="author"><name><surname>Mothana</surname><given-names>R.A.A.</given-names></name><name><surname>Abdo</surname><given-names>S.A.A.</given-names></name><name><surname>Hasson</surname><given-names>S.</given-names></name><name><surname>Althawab</surname><given-names>F.</given-names></name><name><surname>Alaghbari</surname><given-names>S.A.Z.</given-names></name><name><surname>Lindequist</surname><given-names>U.</given-names></name></person-group><article-title>Antimicrobial, antioxidant and cytotoxic activities and phytochemical screening of some yemeni medicinal plants</article-title><source>Evid. base Compl. Alternative Med.</source><volume>7</volume><issue>3</issue><year>2010</year><fpage>323</fpage><lpage>330</lpage></element-citation></ref><ref id="bib63"><label>63</label><element-citation publication-type="journal" id="sref63"><person-group person-group-type="author"><name><surname>Photolo</surname><given-names>M.M.</given-names></name><name><surname>Mavumengwana</surname><given-names>V.</given-names></name><name><surname>Sitole</surname><given-names>L.</given-names></name><name><surname>Tlou</surname><given-names>M.G.</given-names></name></person-group><article-title>Antimicrobial and antioxidant properties of a bacterial endophyte, methylobacterium radiotolerans MAMP 4754, isolated from Combretum erythrophyllum seeds</article-title><source>Int. J. Microbiol.</source><year>2020</year><fpage>2020</fpage></element-citation></ref><ref id="bib64"><label>64</label><element-citation publication-type="journal" id="sref64"><person-group person-group-type="author"><name><surname>Lai</surname><given-names>H.Y.</given-names></name><name><surname>Lim</surname><given-names>Y.Y.</given-names></name><name><surname>Kim</surname><given-names>K.H.</given-names></name></person-group><article-title>Blechnum orientale Linn-a fern with potential as antioxidant, anticancer and antibacterial agent</article-title><source>BMC Compl. Alternative Med.</source><volume>10</volume><issue>1</issue><year>2010</year><fpage>15</fpage><comment>15</comment></element-citation></ref><ref id="bib65"><label>65</label><element-citation publication-type="journal" id="sref65"><person-group person-group-type="author"><name><surname>Laulloo</surname><given-names>S.J.</given-names></name><name><surname>Bhowon</surname><given-names>M.G.</given-names></name><name><surname>Soyfoo</surname><given-names>S.</given-names></name><name><surname>Chua</surname><given-names>L.S.</given-names></name></person-group><article-title>Nutritional and biological evaluation of leaves of Mangifera indica from Mauritius.</article-title><source>J. Chem.</source><year>2018</year><fpage>2018</fpage></element-citation></ref><ref id="bib66"><label>66</label><element-citation publication-type="journal" id="sref66"><person-group person-group-type="author"><name><surname>Tomczykowa</surname><given-names>M.</given-names></name><name><surname>Tomczyk</surname><given-names>M.</given-names></name><name><surname>Jakoniuk</surname><given-names>P.</given-names></name><name><surname>Tryniszewska</surname><given-names>E.</given-names></name></person-group><article-title>Antimicrobial and antifungal activities of the extracts and essential oils of Bidens tripartita</article-title><source>Folia Histochemica et cytobiologica</source><volume>46</volume><issue>3</issue><year>2008</year><fpage>389</fpage><lpage>393</lpage><pub-id pub-id-type="pmid">19056546</pub-id></element-citation></ref><ref id="bib67"><label>67</label><element-citation publication-type="journal" id="sref67"><person-group person-group-type="author"><name><surname>Wojcikowski</surname><given-names>K.</given-names></name><name><surname>Stevenson</surname><given-names>L.</given-names></name><name><surname>Leach</surname><given-names>D.</given-names></name><name><surname>Wohlmuth</surname><given-names>H.</given-names></name><name><surname>Gobe</surname><given-names>G.</given-names></name></person-group><article-title>Antioxidant capacity of 55 medicinal herbs traditionally used to treat the urinary system&#x0202f;: a comparison using a sequential three-solvent extraction process</article-title><source>J.&#x000a0;Alternative Compl. Med.</source><volume>13</volume><issue>1</issue><year>2007</year><fpage>103</fpage><lpage>109</lpage></element-citation></ref><ref id="bib68"><label>68</label><element-citation publication-type="journal" id="sref68"><person-group person-group-type="author"><name><surname>Ngoci</surname><given-names>S.N.</given-names></name><name><surname>Matasyoh</surname><given-names>J.C.</given-names></name><name><surname>Mwaniki</surname><given-names>C.G.</given-names></name><name><surname>Mwendia</surname><given-names>C.M.</given-names></name></person-group><article-title>Antibacterial activity of methanol root extract of Indigofera lupatana Baker F</article-title><source>E.&#x000a0;J. Med.</source><volume>17</volume><issue>1</issue><year>2012</year><fpage>11</fpage><lpage>16</lpage></element-citation></ref><ref id="bib69"><label>69</label><element-citation publication-type="journal" id="sref69"><person-group person-group-type="author"><name><surname>Iwatsuki</surname><given-names>M.</given-names></name><name><surname>Uchida</surname><given-names>R.</given-names></name><name><surname>Takakusagi</surname><given-names>Y.</given-names></name><name><surname>Matsumoto</surname><given-names>A.</given-names></name><name><surname>Jiang</surname><given-names>C.L.</given-names></name><name><surname>Takahashi</surname><given-names>Y.</given-names></name><name><surname>Arai</surname><given-names>M.</given-names></name><name><surname>Kobayashi</surname><given-names>S.</given-names></name><name><surname>Matsumoto</surname><given-names>M.</given-names></name><name><surname>Inokoshi</surname><given-names>J.</given-names></name><name><surname>Tomoda</surname><given-names>H.</given-names></name><name><surname>Omura</surname><given-names>S.</given-names></name></person-group><article-title>Lariatins, novel anti-mycobacterial peptides with a lasso structure, produced by Rhodococcus jostii K01-B0171</article-title><source>J.&#x000a0;Antibiot. (Tokyo)</source><volume>60</volume><issue>6</issue><year>2007</year><fpage>357</fpage><lpage>363</lpage><pub-id pub-id-type="pmid">17617692</pub-id></element-citation></ref><ref id="bib70"><label>70</label><element-citation publication-type="journal" id="sref70"><person-group person-group-type="author"><name><surname>Koyama</surname><given-names>N.</given-names></name><name><surname>Kojima</surname><given-names>S.</given-names></name><name><surname>Nonaka</surname><given-names>K.</given-names></name><name><surname>Masuma</surname><given-names>R.</given-names></name><name><surname>Matsumoto</surname><given-names>M.</given-names></name><name><surname>&#x0014c;mura</surname><given-names>S.</given-names></name><name><surname>Tomoda</surname><given-names>H.</given-names></name></person-group><article-title>Calpinactam, a new anti-mycobacterial agent, produced by Mortierella alpina FKI-4905</article-title><source>J.&#x000a0;Antibiot.</source><volume>63</volume><issue>4</issue><year>2010</year><fpage>183</fpage><lpage>186</lpage></element-citation></ref><ref id="bib71"><label>71</label><element-citation publication-type="journal" id="sref71"><person-group person-group-type="author"><name><surname>Davies</surname><given-names>J.</given-names></name><name><surname>Davies</surname><given-names>D.</given-names></name></person-group><article-title>Origins and evolution of antibiotic resistance</article-title><source>Microbiol. Mol. Biol. Rev.</source><volume>74</volume><issue>3</issue><year>2010</year><fpage>417</fpage><lpage>433</lpage><pub-id pub-id-type="pmid">20805405</pub-id></element-citation></ref><ref id="bib72"><label>72</label><element-citation publication-type="journal" id="sref72"><person-group person-group-type="author"><name><surname>Nathan</surname><given-names>C.</given-names></name></person-group><article-title>Antibiotics at the crossroads</article-title><source>Nature</source><volume>431</volume><issue>7011</issue><year>2004</year><fpage>899</fpage><lpage>902</lpage><pub-id pub-id-type="pmid">15496893</pub-id></element-citation></ref><ref id="bib73"><label>73</label><element-citation publication-type="journal" id="sref73"><person-group person-group-type="author"><name><surname>Ashraf</surname><given-names>A.</given-names></name><name><surname>Sarfraz</surname><given-names>R.A.</given-names></name><name><surname>Rashid</surname><given-names>M.A.</given-names></name><name><surname>Shahid</surname><given-names>M.</given-names></name></person-group><article-title>Antioxidant, antimicrobial, antitumor, and cytotoxic activities of an important medicinal plant (Euphorbia royleana) from Pakistan</article-title><source>J.&#x000a0;Food Drug Anal.</source><volume>23</volume><issue>1</issue><year>2015</year><fpage>109</fpage><lpage>115</lpage><pub-id pub-id-type="pmid">28911432</pub-id></element-citation></ref><ref id="bib74"><label>74</label><element-citation publication-type="journal" id="sref74"><person-group person-group-type="author"><name><surname>Cowan</surname><given-names>M.M.</given-names></name></person-group><article-title>Plant products as antimicrobial agents</article-title><source>Clin. Microbiol. Rev.</source><volume>12</volume><issue>4</issue><year>1999</year><fpage>564</fpage><lpage>582</lpage><pub-id pub-id-type="pmid">10515903</pub-id></element-citation></ref><ref id="bib75"><label>75</label><element-citation publication-type="journal" id="sref75"><person-group person-group-type="author"><name><surname>Santhosh</surname><given-names>R.S.</given-names></name><name><surname>Suriyanarayanan</surname><given-names>B.</given-names></name></person-group><article-title>Plants : a source for new antimycobacterial drugs</article-title><source>Planta Med.</source><volume>80</volume><issue>1</issue><year>2014</year><fpage>9</fpage><lpage>21</lpage><pub-id pub-id-type="pmid">24218370</pub-id></element-citation></ref><ref id="bib76"><label>76</label><element-citation publication-type="journal" id="sref76"><person-group person-group-type="author"><name><surname>Caesar</surname><given-names>L.K.</given-names></name><name><surname>Cech</surname><given-names>N.B.</given-names></name></person-group><article-title>Synergy and antagonism in natural product extracts: when 1 + 1 does not equal 2</article-title><source>Nat. Prod. Rep.</source><volume>36</volume><issue>6</issue><year>2019</year><fpage>869</fpage><lpage>888</lpage><pub-id pub-id-type="pmid">31187844</pub-id></element-citation></ref><ref id="bib77"><label>77</label><element-citation publication-type="journal" id="sref77"><person-group person-group-type="author"><name><surname>Junio</surname><given-names>H.A.</given-names></name><name><surname>Sy-Cordero</surname><given-names>A.A.</given-names></name><name><surname>Ettefagh</surname><given-names>K.A.</given-names></name><name><surname>Burns</surname><given-names>J.T.</given-names></name><name><surname>Micko</surname><given-names>K.T.</given-names></name><name><surname>Graf</surname><given-names>T.N.</given-names></name><name><surname>Richter</surname><given-names>S.J.</given-names></name><name><surname>Cannon</surname><given-names>R.E.</given-names></name><name><surname>Oberlies</surname><given-names>N.H.</given-names></name><name><surname>Cech</surname><given-names>N.B.</given-names></name></person-group><article-title>Synergy-directed fractionation of botanical medicines: a case study with goldenseal (hydrastis canadensis)</article-title><source>J.&#x000a0;Nat. Prod.</source><volume>74</volume><issue>7</issue><year>2011</year><fpage>1621</fpage><lpage>1629</lpage><pub-id pub-id-type="pmid">21661731</pub-id></element-citation></ref><ref id="bib78"><label>78</label><element-citation publication-type="journal" id="sref78"><person-group person-group-type="author"><name><surname>Stermitz</surname><given-names>F.R.</given-names></name><name><surname>Scriven</surname><given-names>L.N.</given-names></name><name><surname>Tegos</surname><given-names>G.</given-names></name><name><surname>Lewis</surname><given-names>K.</given-names></name></person-group><article-title>Two flavonols from Artemisa annua which potentiate the activity of berberine and norfloxacin against a resistant strain of Staphylococcus aureus</article-title><source>Planta Med.</source><volume>68</volume><issue>12</issue><year>2002</year><fpage>1140</fpage><lpage>1141</lpage><pub-id pub-id-type="pmid">12494348</pub-id></element-citation></ref><ref id="bib79"><label>79</label><element-citation publication-type="journal" id="sref79"><person-group person-group-type="author"><name><surname>Wagner</surname><given-names>H.</given-names></name><name><surname>Ulrich-Merzenich</surname><given-names>G.</given-names></name></person-group><article-title>Synergy research: approaching a new generation of phytopharmaceuticals</article-title><source>Phytomedicine</source><volume>16</volume><issue>2-3</issue><year>2009</year><fpage>97</fpage><lpage>110</lpage><pub-id pub-id-type="pmid">19211237</pub-id></element-citation></ref><ref id="bib80"><label>80</label><element-citation publication-type="book" id="sref80"><person-group person-group-type="author"><name><surname>Ayob</surname><given-names>M.K.</given-names></name><name><surname>Tan</surname><given-names>Y.N.</given-names></name></person-group><chapter-title>Natural Products-Current and Future Promising Source of Novel Drugs : A Review on Their Antimicrobial Mechanism of Actions</chapter-title><year>2013</year><publisher-name>Formatex</publisher-name><fpage>1196</fpage><lpage>1208</lpage></element-citation></ref><ref id="bib81"><label>81</label><element-citation publication-type="journal" id="sref81"><person-group person-group-type="author"><name><surname>Caillet</surname><given-names>S.</given-names></name><name><surname>C&#x000f4;t&#x000e9;</surname><given-names>J.</given-names></name><name><surname>Sylvain</surname><given-names>J.-F.</given-names></name><name><surname>Lacroix</surname><given-names>M.</given-names></name></person-group><article-title>Antimicrobial effects of fractions from cranberry products on the growth of seven pathogenic bacteria</article-title><source>Food Contr.</source><volume>23</volume><issue>2</issue><year>2012</year><fpage>419</fpage><lpage>428</lpage></element-citation></ref><ref id="bib82"><label>82</label><element-citation publication-type="journal" id="sref82"><person-group person-group-type="author"><name><surname>Gurib-Fakim</surname><given-names>A.</given-names></name></person-group><article-title>Medicinal plants: traditions of yesterday and drugs of tomorrow</article-title><source>Mol. Aspect. Med.</source><volume>27</volume><issue>1</issue><year>2006</year><fpage>1</fpage><lpage>93</lpage></element-citation></ref><ref id="bib83"><label>83</label><element-citation publication-type="journal" id="sref83"><person-group person-group-type="author"><name><surname>Kareru</surname><given-names>P.G.</given-names></name><name><surname>Nyabola</surname><given-names>A.O.</given-names></name><name><surname>Madivoli</surname><given-names>E.S.</given-names></name><name><surname>Wanakai</surname><given-names>S.I.</given-names></name><name><surname>Maina</surname><given-names>E.G.</given-names></name></person-group><article-title>Formation of silver nanoparticles via Aspilia pluriseta extracts their antimicrobial and catalytic activity</article-title><source>J.&#x000a0;Inorg. Organomet. Polym. Mater.</source><volume>30</volume><year>2020</year><fpage>3493</fpage><lpage>3501</lpage></element-citation></ref><ref id="bib84"><label>84</label><element-citation publication-type="journal" id="sref84"><person-group person-group-type="author"><name><surname>Nyabola</surname><given-names>A.O.</given-names></name><name><surname>Kareru</surname><given-names>P.G.</given-names></name><name><surname>Madivoli</surname><given-names>E.S.</given-names></name><name><surname>Maina</surname><given-names>E.G.</given-names></name><name><surname>Wanakai</surname><given-names>I.S.</given-names></name></person-group><article-title>Assessment of the anti-microbial action of zero valent iron nanoparticle synthesized by Aspilia pluriseta extracts</article-title><source>Chem. Sci. Int. J.</source><volume>25</volume><issue>3</issue><year>2018</year><fpage>1</fpage><lpage>10</lpage></element-citation></ref><ref id="bib85"><label>85</label><element-citation publication-type="journal" id="sref85"><person-group person-group-type="author"><name><surname>Cantrell</surname><given-names>C.L.</given-names></name><name><surname>Franzblau</surname><given-names>S.G.</given-names></name><name><surname>Fischer</surname><given-names>N.H.</given-names></name></person-group><article-title>Review; Antimycobacterial Plant Terpenoids</article-title><source>Planta Med.</source><volume>67</volume><year>2001</year><fpage>685</fpage><lpage>694</lpage><pub-id pub-id-type="pmid">11731906</pub-id></element-citation></ref><ref id="bib86"><label>86</label><element-citation publication-type="journal" id="sref86"><person-group person-group-type="author"><name><surname>Higuchi</surname><given-names>C.T.</given-names></name><name><surname>Pavan</surname><given-names>F.R.</given-names></name><name><surname>Leite</surname><given-names>C.Q.F.</given-names></name><name><surname>Sannomiya</surname><given-names>M.</given-names></name><name><surname>Vilegas</surname><given-names>W.</given-names></name><name><surname>Leite</surname><given-names>S.R.D.A.</given-names></name><name><surname>Sacramento</surname><given-names>L.V.S.</given-names></name><name><surname>Sato</surname><given-names>D.N.</given-names></name></person-group><article-title>Triterpenes and antitubercular activity of Byrsonima crassa</article-title><source>Quim. Nova</source><volume>31</volume><issue>7</issue><year>2008</year><fpage>1719</fpage><lpage>1721</lpage></element-citation></ref><ref id="bib87"><label>87</label><element-citation publication-type="journal" id="sref87"><person-group person-group-type="author"><name><surname>Sieniawska</surname><given-names>E.</given-names></name><name><surname>Swatko-Ossor</surname><given-names>M.</given-names></name><name><surname>Sawicki</surname><given-names>R.</given-names></name><name><surname>Skalicka-Wo&#x0017a;niak</surname><given-names>K.</given-names></name><name><surname>Ginalska</surname><given-names>G.</given-names></name></person-group><article-title>Natural terpenes influence the activity of antibiotics against isolated Mycobacterium tuberculosis</article-title><source>Med. Princ. Pract.</source><volume>26</volume><issue>2</issue><year>2017</year><fpage>108</fpage><lpage>112</lpage><pub-id pub-id-type="pmid">27883995</pub-id></element-citation></ref><ref id="bib88"><label>88</label><element-citation publication-type="journal" id="sref88"><person-group person-group-type="author"><name><surname>Chandrasekaran</surname><given-names>M.</given-names></name><name><surname>Kannathasan</surname><given-names>K.</given-names></name><name><surname>Venkatesalu</surname><given-names>V.</given-names></name></person-group><article-title>Antimicrobial activity of fatty acid methyl esters of some members of chenopodiaceae</article-title><source>Zeitschrift fur Naturforschung - Section C Journal of Biosciences</source><volume>63</volume><issue>5-6</issue><year>2008</year><fpage>7</fpage><lpage>12</lpage></element-citation></ref><ref id="bib89"><label>89</label><element-citation publication-type="journal" id="sref89"><person-group person-group-type="author"><name><surname>Chandrasekaran</surname><given-names>M.</given-names></name><name><surname>Senthilkumar</surname><given-names>a.</given-names></name><name><surname>Venkatesalu</surname><given-names>V.</given-names></name></person-group><article-title>Antibacterial and antifungal efficacy of fatty acid methyl esters from the leaves of Sesuvium portulacastrum L</article-title><source>Eur. Rev. Med. Pharmacol. Sci.</source><volume>15</volume><issue>7</issue><year>2011</year><fpage>775</fpage><lpage>780</lpage><pub-id pub-id-type="pmid">21780546</pub-id></element-citation></ref><ref id="bib90"><label>90</label><element-citation publication-type="journal" id="sref90"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>C.B.</given-names></name><name><surname>Altimova</surname><given-names>Y.</given-names></name><name><surname>Myers</surname><given-names>T.M.</given-names></name><name><surname>Ebersole</surname><given-names>J.L.</given-names></name></person-group><article-title>Short- and medium-chain fatty acids exhibit antimicrobial activity for oral microorganisms</article-title><source>Arch. Oral Biol.</source><volume>56</volume><issue>7</issue><year>2011</year><fpage>650</fpage><lpage>654</lpage><pub-id pub-id-type="pmid">21333271</pub-id></element-citation></ref><ref id="bib91"><label>91</label><element-citation publication-type="journal" id="sref91"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>Q.</given-names></name><name><surname>Wang</surname><given-names>M.</given-names></name><name><surname>Li</surname><given-names>J.</given-names></name><name><surname>Shi</surname><given-names>W.</given-names></name><name><surname>Wang</surname><given-names>H.</given-names></name><name><surname>Zhao</surname><given-names>C.</given-names></name></person-group><article-title>Analysis of fatty acids, aliphatic esters, and in vitro studies of antioxidant and antimicrobial activities for recineckea carnea and tupistra chinensis from the guizhou province</article-title><source>J.&#x000a0;Med. Food</source><volume>17</volume><issue>2</issue><year>2013</year><fpage>236</fpage><lpage>243</lpage><pub-id pub-id-type="pmid">24320985</pub-id></element-citation></ref><ref id="bib92"><label>92</label><element-citation publication-type="journal" id="sref92"><person-group person-group-type="author"><name><surname>Morbidoni</surname><given-names>H.R.</given-names></name><name><surname>Vilch&#x000e8;ze</surname><given-names>C.</given-names></name><name><surname>Kremer</surname><given-names>L.</given-names></name><name><surname>Bittman</surname><given-names>R.</given-names></name><name><surname>Sacchettini</surname><given-names>J.C.</given-names></name><name><surname>Jacobs</surname><given-names>W.R.</given-names></name></person-group><article-title>Dual inhibition of mycobacterial fatty acid biosynthesis and degradation by 2-alkynoic acids</article-title><source>Chem. Biol.</source><volume>13</volume><issue>3</issue><year>2006</year><fpage>297</fpage><lpage>307</lpage><pub-id pub-id-type="pmid">16638535</pub-id></element-citation></ref><ref id="bib93"><label>93</label><element-citation publication-type="journal" id="sref93"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>S.C.a.</given-names></name><name><surname>Biswas</surname><given-names>C.</given-names></name><name><surname>Bartley</surname><given-names>R.</given-names></name><name><surname>Widmer</surname><given-names>F.</given-names></name><name><surname>Pantarat</surname><given-names>N.</given-names></name><name><surname>Obando</surname><given-names>D.</given-names></name><name><surname>Djordjevic</surname><given-names>J.T.</given-names></name><name><surname>Ellis</surname><given-names>D.H.</given-names></name><name><surname>Jolliffe</surname><given-names>K.a.</given-names></name><name><surname>Sorrell</surname><given-names>T.C.</given-names></name></person-group><article-title>In vitro antifungal activities of bis(alkylpyridinium)alkane compounds against pathogenic yeasts and molds</article-title><source>Antimicrob. Agents Chemother.</source><volume>54</volume><issue>8</issue><year>2010</year><fpage>3233</fpage><lpage>3240</lpage><pub-id pub-id-type="pmid">20530227</pub-id></element-citation></ref><ref id="bib94"><label>94</label><element-citation publication-type="journal" id="sref94"><person-group person-group-type="author"><name><surname>Lunde</surname><given-names>C.S.</given-names></name><name><surname>Hartouni</surname><given-names>S.R.</given-names></name><name><surname>Janc</surname><given-names>J.W.</given-names></name><name><surname>Mammen</surname><given-names>M.</given-names></name><name><surname>Humphrey</surname><given-names>P.P.</given-names></name><name><surname>Benton</surname><given-names>B.M.</given-names></name></person-group><article-title>Telavancin disrupts the functional integrity of the bacterial membrane through targeted interaction with the cell wall precursor lipid II</article-title><source>Antimicrob. Agents Chemother.</source><volume>53</volume><issue>8</issue><year>2009</year><fpage>3375</fpage><lpage>3383</lpage><pub-id pub-id-type="pmid">19470513</pub-id></element-citation></ref><ref id="bib95"><label>95</label><element-citation publication-type="journal" id="sref95"><person-group person-group-type="author"><name><surname>Martins</surname><given-names>C.d.M.</given-names></name><name><surname>do Nascimento</surname><given-names>E.A.</given-names></name><name><surname>de Morais</surname><given-names>S.A.L.</given-names></name><name><surname>de Oliveira</surname><given-names>A.</given-names></name><name><surname>Chang</surname><given-names>R.</given-names></name><name><surname>Cunha</surname><given-names>L.C.S.</given-names></name><name><surname>Martins</surname><given-names>M.M.</given-names></name><name><surname>Martins</surname><given-names>C.H.G.</given-names></name><name><surname>Moraes</surname><given-names>T.d.S.</given-names></name><name><surname>Rodrigues</surname><given-names>P.V.</given-names></name><name><surname>da Silva</surname><given-names>C.V.</given-names></name><name><surname>de Aquino</surname><given-names>F.J.T.</given-names></name></person-group><article-title>Chemical constituents and evaluation of antimicrobial and cytotoxic activities of kielmeyera coriacea mart. &#x00026; zucc. Essential oils</article-title><source>Evid. base Compl. Alternative Med. : eCAM</source><volume>2015</volume><year>2015</year><fpage>842047</fpage><comment>842047</comment></element-citation></ref></ref-list><ack id="ack0010"><title>Acknowledgements</title><p>The authors would wish to acknowledge KEMRI- especially Dr. Bii C., among others, Kisii University (Prof. Anakalo S.) and Egerton University, (Prof. Ngari S.M., Dr. Obonyo A.M, Prof. Matasyoh J.C., and Mr. Nyambati S.O.) for the support they gave to the work.</p></ack></back></article>